(625945, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0001666', 'abnormal intestinal absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(625946, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0003464', 'abnormal single cell response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625947, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0002887', 'decreased susceptibility to pharmacologically induced seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625948, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625949, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(625950, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0003926', 'decreased cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(625951, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0014255', 'increased paired-pulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625952, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0008005', 'decreased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(625953, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(625954, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0001629', 'abnormal heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(625955, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0000751', 'myopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(625956, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(625957, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625958, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0009562', 'abnormal odor adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(625959, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0011397', 'endoneurial edema', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625960, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0014252', 'abnormal paired-pulse ratio', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625961, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0020424', 'increased kindling response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625962, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0003489', 'increased channel response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625963, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0030991', 'optic nerve inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625964, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0003880', 'abnormal central pattern generator function', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625965, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0001475', 'reduced long-term depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625966, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0014274', 'decreased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(625967, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0014120', 'focal seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625968, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0000423', 'delayed hair regrowth', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(625969, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625970, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0004143', 'muscle hypertonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(625971, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0003480', 'increased nerve fiber response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625972, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0003927', 'increased cellular glucose import', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(625973, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0020155', 'enhanced humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(625974, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625975, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0003468', 'increased single cell response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625976, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0003088', 'abnormal prepulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625977, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0003482', 'increased nerve fiber response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625978, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0005501', 'abnormal skin physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(625979, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0001902', 'reduced NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625980, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0030924', 'early exit from telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(625981, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0004037', 'increased muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(625982, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(625983, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0011271', 'prolonged excitatory postsynaptic current rise time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625984, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0010822', 'pneumothorax', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(625985, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0003925', 'abnormal cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(625986, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0011268', 'biphasic excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625987, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(625988, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0013639', 'decreased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(625989, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0003635', 'abnormal synaptic transmission', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625990, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0021015', 'increased tau protein phosphorylation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625991, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0004835', 'abnormal miniature endplate potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625992, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0000313', 'abnormal cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(625993, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(625994, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0006052', 'cerebellum hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625995, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0000947', 'convulsive seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625996, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0006051', 'brainstem hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(625997, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0001933', 'abnormal litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(625998, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0013559', 'abnormal exocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(625999, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0001845', 'abnormal inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626000, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0005620', 'abnormal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626001, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626002, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0008006', 'increased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626003, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626004, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626005, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0011272', 'short excitatory postsynaptic current rise time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626006, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0001499', 'abnormal kindling response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626007, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0002106', 'abnormal muscle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626008, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626009, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0003298', 'choking', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626010, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0003412', 'abnormal afterhyperpolarization', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626011, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626012, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626013, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0031098', 'abnormal sputum production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626014, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626015, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626016, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0012011', 'febrile seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626017, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626018, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626019, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0031302', 'syncope', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626020, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0001900', 'impaired synaptic plasticity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626021, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626022, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626023, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0011048', 'decreased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626024, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0002888', 'abnormal NMDA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626025, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626026, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626027, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0000316', 'cellular necrosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626028, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626029, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626030, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0002885', 'abnormal AMPA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626031, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626032, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0008861', 'abnormal hair shedding', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626033, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0001800', 'abnormal humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626034, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0002128', 'abnormal blood circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626035, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0000351', 'increased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626036, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0003487', 'increased channel response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626037, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0002896', 'abnormal bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626038, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0001984', 'abnormal olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626039, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0002419', 'abnormal innate immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626040, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0013438', 'dysmyelination', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626041, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0003621', 'dysuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626042, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0031109', 'subarachnoid hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626043, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0001761', 'abnormal urination pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626044, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626045, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0020154', 'impaired humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626046, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0014275', 'increased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626047, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0008840', 'abnormal spike wave discharge', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626048, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626049, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0001648', 'abnormal apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626050, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626051, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0030951', 'abnormal endocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626052, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626053, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0000352', 'decreased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626054, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0010950', 'abnormal lung hysteresivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626055, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0005666', 'abnormal adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626056, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0004494', 'abnormal synaptic glutamate release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626057, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626058, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0002064', 'seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626059, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0030988', 'dysosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626060, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0005025', 'abnormal response to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626061, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0002161', 'abnormal fertility/fecundity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626062, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626063, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0010143', 'enhanced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626064, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0003218', 'decreased spike-wave discharge type I', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626065, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0005410', 'abnormal fertilization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626066, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626067, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0004213', 'abnormal umami taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626068, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0005005', 'abnormal self tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626069, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0020848', 'abnormal exocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626070, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626071, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626072, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0030214', 'muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626073, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0003216', 'absence seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626074, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0002634', 'abnormal sensorimotor gating', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626075, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0001985', 'abnormal gustatory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626076, 'HP:5200012', 'Abnormal speech rhythm', 'MP:0002915', 'abnormal synaptic depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(626077, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0021035', 'decreased circulating cartilage oligomeric matrix protein level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626078, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0031107', 'abnormal circulating myoglobin level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(626079, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0031069', 'increased blood oxygen saturation level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626080, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0031163', 'abnormal circulating von Willebrand factor level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(626081, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0012617', 'abnormal circulating factor X level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(626082, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0030757', 'abnormal circulating histamine level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626083, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0013403', 'abnormal circulating lactate level', 0.4594594594594595, 7.550058075704454, 1.862510564359487, 'UPHENO:0076286', 'abnormal role blood level'),
(626084, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0011893', 'increased circulating transferrin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626085, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0031082', 'decreased circulating D-dimer level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626086, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0008820', 'abnormal blood uric acid level', 0.4473684210526316, 7.550058075704454, 1.8378404610258128, 'UPHENO:0076286', 'abnormal role blood level'),
(626087, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0014162', 'decreased circulating cortisol level', 0.4222222222222222, 10.169741955603977, 2.0721706126479256, 'UPHENO:0076293', 'abnormal hormone blood level'),
(626088, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0012327', 'abnormal circulating factor VIII level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(626089, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0031078', 'increased circulating troponin T level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(626090, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0012664', 'decreased circulating haptoglobin level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(626091, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0031081', 'abnormal circulating D-dimer level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(626092, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0003366', 'abnormal circulating glucocorticoid level', 0.4418604651162791, 10.169741955603977, 2.1198129423644225, 'UPHENO:0076293', 'abnormal hormone blood level'),
(626093, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0031074', 'increased circulating type I collagen C-terminal telopeptide level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626094, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0031064', 'abnormal circulating procalcitonin level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(626095, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0011895', 'abnormal circulating unsaturated transferrin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626096, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0020256', 'abnormal circulating factor XII level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(626097, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0012324', 'abnormal circulating antithrombin level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(626098, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0013256', 'increased circulating thrombin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626099, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0011611', 'abnormal circulating ghrelin level', 0.475, 10.169741955603977, 2.197868837968246, 'UPHENO:0076293', 'abnormal hormone blood level'),
(626100, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0021034', 'abnormal circulating cartilage oligomeric matrix protein level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(626101, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0012614', 'abnormal circulating factor IX level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(626102, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0005660', 'abnormal circulating adrenaline level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(626103, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0031076', 'decreased circulating troponin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626104, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0031068', 'decreased blood oxygen saturation level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626105, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0031075', 'abnormal circulating troponin level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(626106, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0005184', 'abnormal circulating progesterone level', 0.41304347826086957, 10.169741955603977, 2.0495232592869406, 'UPHENO:0076293', 'abnormal hormone blood level'),
(626107, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0005183', 'abnormal circulating estradiol level', 0.41304347826086957, 10.169741955603977, 2.0495232592869406, 'UPHENO:0076293', 'abnormal hormone blood level'),
(626108, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0031065', 'increased circulating procalcitonin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626109, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0003018', 'abnormal circulating chloride level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(626110, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0031114', 'increased circulating gamma-glutamyl transferase level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(626111, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0005311', 'abnormal circulating amino acid level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(626112, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0000188', 'abnormal circulating glucose level', 0.4473684210526316, 7.550058075704454, 1.8378404610258128, 'UPHENO:0076286', 'abnormal role blood level'),
(626113, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0005416', 'abnormal circulating protein level', 0.4358974358974359, 7.550058075704454, 1.8141253970098927, 'UPHENO:0076286', 'abnormal role blood level'),
(626114, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0011912', 'abnormal circulating fibronectin level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(626115, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0011888', 'abnormal circulating total protein level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(626116, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0012328', 'decreased circulating factor VIII level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626117, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0020983', 'abnormal circulating factor XI level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(626118, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0031164', 'decreased circulating von Willebrand factor level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626119, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0003372', 'abnormal circulating mineralocorticoid level', 0.4418604651162791, 10.169741955603977, 2.1198129423644225, 'UPHENO:0076293', 'abnormal hormone blood level'),
(626120, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0020246', 'abnormal circulating arginase level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(626121, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0014161', 'increased circulating cortisol level', 0.4222222222222222, 10.169741955603977, 2.0721706126479256, 'UPHENO:0076293', 'abnormal hormone blood level'),
(626122, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0011891', 'decreased circulating ferritin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626123, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0031077', 'increased circulating troponin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626124, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0031083', 'increased circulating D-dimer level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626125, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0013255', 'abnormal circulating thrombin level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(626126, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0020341', 'abnormal circulating hyaluronic acid level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626127, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0011892', 'abnormal circulating transferrin level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(626128, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0012666', 'increased circulating haptoglobin level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(626129, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0001570', 'abnormal circulating enzyme level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626130, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0011890', 'increased circulating ferritin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626131, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0014160', 'abnormal circulating cortisol level', 0.4318181818181818, 10.169741955603977, 2.0955857130714053, 'UPHENO:0076293', 'abnormal hormone blood level'),
(626132, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0010216', 'abnormal circulating retinol binding protein level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(626133, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0005611', 'decreased circulating antidiuretic hormone level', 0.40425531914893614, 10.169741955603977, 2.027602594179888, 'UPHENO:0076293', 'abnormal hormone blood level'),
(626134, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0031108', 'increased circulating myoglobin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626135, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0003457', 'abnormal circulating ketone body level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(626136, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0012325', 'decreased circulating antithrombin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626137, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0031067', 'abnormal blood oxygen saturation level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(626138, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0012221', 'abnormal circulating prothrombin level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(626139, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0011885', 'abnormal circulating lipase level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(626140, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0005265', 'abnormal blood urea nitrogen level', 0.4473684210526316, 7.550058075704454, 1.8378404610258128, 'UPHENO:0076286', 'abnormal role blood level'),
(626141, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0012329', 'increased circulating factor VIII level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626142, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0012549', 'hypoxemia', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(626143, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0013257', 'decreased circulating thrombin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626144, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0012222', 'decreased circulating prothrombin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626145, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0013277', 'abnormal fasting circulating glucose level', 0.4358974358974359, 7.550058075704454, 1.8141253970098927, 'UPHENO:0076286', 'abnormal role blood level'),
(626146, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0008804', 'abnormal circulating amylase level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(626147, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0031073', 'decreased circulating type I collagen C-terminal telopeptide level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626148, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0003015', 'abnormal circulating bicarbonate level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626149, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0012223', 'increased circulating prothrombin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626150, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0020986', 'abnormal circulating ceruloplasmin level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(626151, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0010106', 'abnormal circulating pyruvate kinase level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(626152, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0012620', 'abnormal circulating factor XIII level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(626153, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0012332', 'decreased circulating fibronectin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626154, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0001569', 'abnormal circulating bilirubin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626155, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0002329', 'abnormal blood gas level', 0.4358974358974359, 7.550058075704454, 1.8141253970098927, 'UPHENO:0076286', 'abnormal role blood level'),
(626156, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0005346', 'abnormal circulating aldosterone level', 0.41304347826086957, 10.169741955603977, 2.0495232592869406, 'UPHENO:0076293', 'abnormal hormone blood level'),
(626157, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0021036', 'increased circulating cartilage oligomeric matrix protein level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626158, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0012333', 'increased circulating fibronectin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626159, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0011894', 'decreased circulating transferrin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626160, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0031072', 'abnormal circulating type I collagen C-terminal telopeptide level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(626161, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0005308', 'abnormal circulating ammonia level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626162, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0031079', 'increased circulating troponin I level', 0.40476190476190477, 7.550058075704454, 1.7481349741324714, 'UPHENO:0076286', 'abnormal role blood level'),
(626163, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0031165', 'increased circulating von Willebrand factor level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626164, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0012326', 'increased circulating antithrombin level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626165, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0003508', 'abnormal circulating dihydrotestosterone level', 0.40425531914893614, 10.169741955603977, 2.027602594179888, 'UPHENO:0076293', 'abnormal hormone blood level'),
(626166, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0031340', 'abnormal circulating lipocalin 2 level', 0.4146341463414634, 7.550058075704454, 1.7693252626490665, 'UPHENO:0076286', 'abnormal role blood level'),
(626167, 'HP:0031102', 'Increased circulating antimullerian hormone concentration', 'MP:0011889', 'abnormal circulating ferritin level', 0.425, 7.550058075704454, 1.791305301218749, 'UPHENO:0076286', 'abnormal role blood level'),
(626168, 'HP:0008559', 'Hypoplastic superior helix', 'MP:0000018', 'small ears', 0.4444444444444444, 10.255471829629862, 2.134944373944083, 'UPHENO:0086699', 'abnormal external ear morphology'),
(626169, 'HP:0008559', 'Hypoplastic superior helix', 'MP:0000435', 'shortened head', 0.40350877192982454, 6.5236679405794336, 1.622454079221096, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(626170, 'HP:0008559', 'Hypoplastic superior helix', 'MP:0000022', 'abnormal ear shape', 0.4716981132075472, 11.115294171581601, 2.2897736325850833, 'UPHENO:0005986', 'abnormal shape of external ear'),
(626171, 'HP:0008559', 'Hypoplastic superior helix', 'MP:0020084', 'short ears', 0.4067796610169492, 10.255471829629862, 2.0424782384215767, 'UPHENO:0086699', 'abnormal external ear morphology'),
(626172, 'HP:0008559', 'Hypoplastic superior helix', 'MP:0030297', 'outer ear hypoplasia', 0.47368421052631576, 10.255471829629862, 2.20405423644544, 'UPHENO:0086699', 'abnormal external ear morphology'),
(626173, 'HP:0008559', 'Hypoplastic superior helix', 'MP:0003679', 'ear lobe hypoplasia', 0.47368421052631576, 10.255471829629862, 2.20405423644544, 'UPHENO:0086699', 'abnormal external ear morphology'),
(626174, 'HP:0008559', 'Hypoplastic superior helix', 'MP:0006286', 'inner ear hypoplasia', 0.43103448275862066, 8.202005804774931, 1.8802519324931877, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(626175, 'HP:0008559', 'Hypoplastic superior helix', 'MP:0003736', 'folded helix', 0.4126984126984127, 12.607147267911277, 2.2809975155887643, 'UPHENO:0083647', 'abnormal helix of outer ear morphology'),
(626176, 'HP:0008559', 'Hypoplastic superior helix', 'MP:0003735', 'cup-shaped ears', 0.4482758620689655, 12.607147267911277, 2.37728412474263, 'UPHENO:0083647', 'abnormal helix of outer ear morphology'),
(626177, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0008614', 'increased circulating interleukin-17 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(626178, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0008632', 'increased circulating interleukin-16 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(626179, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0008611', 'increased circulating interleukin-15 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(626180, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0005522', 'increased circulating atrial natriuretic factor', 0.5, 11.397693902282326, 2.387225785538763, 'UPHENO:0068533', 'increased level of protein in blood'),
(626181, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0008623', 'increased circulating interleukin-3 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(626182, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0008577', 'increased circulating interferon-gamma level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(626183, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0002904', 'increased circulating parathyroid hormone level', 0.5, 11.397693902282326, 2.387225785538763, 'UPHENO:0068533', 'increased level of protein in blood'),
(626184, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0001754', 'increased circulating corticotropin-releasing hormone level', 0.5205479452054794, 11.397693902282326, 2.4357845021499926, 'UPHENO:0068533', 'increased level of protein in blood'),
(626185, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0008629', 'increased circulating interleukin-9 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(626186, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0005568', 'increased circulating total protein level', 0.4657534246575342, 9.97294124817027, 2.1552103238996625, 'UPHENO:0082534', 'increased bodily fluid base level'),
(626187, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0008591', 'increased circulating interleukin-1 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(626188, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0008605', 'increased circulating interleukin-7 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(626189, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0005343', 'increased circulating aspartate transaminase level', 0.5194805194805194, 11.397693902282326, 2.4332858338546197, 'UPHENO:0068533', 'increased level of protein in blood'),
(626190, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0008593', 'increased circulating interleukin-10 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(626191, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0008599', 'increased circulating interleukin-2 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(626192, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0008638', 'increased circulating interleukin-1 alpha level', 0.425531914893617, 11.397693902282326, 2.202290287770779, 'UPHENO:0068533', 'increased level of protein in blood'),
(626193, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0005122', 'increased circulating thyroid-stimulating hormone level', 0.4634146341463415, 11.397693902282326, 2.2982293510087612, 'UPHENO:0068533', 'increased level of protein in blood'),
(626194, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0008596', 'increased circulating interleukin-6 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(626195, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0002079', 'increased circulating insulin level', 0.4935064935064935, 11.397693902282326, 2.371673660471797, 'UPHENO:0068533', 'increased level of protein in blood'),
(626196, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0004702', 'increased circulating insulin-like growth factor I level', 0.48717948717948717, 11.397693902282326, 2.3564215816238554, 'UPHENO:0068533', 'increased level of protein in blood'),
(626197, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0003352', 'increased circulating renin level', 0.5194805194805194, 11.397693902282326, 2.4332858338546197, 'UPHENO:0068533', 'increased level of protein in blood'),
(626198, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0008553', 'increased circulating tumor necrosis factor level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(626199, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0002712', 'increased circulating glucagon level', 0.4935064935064935, 11.397693902282326, 2.371673660471797, 'UPHENO:0068533', 'increased level of protein in blood'),
(626200, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0008635', 'increased circulating interleukin-18 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(626201, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0006375', 'increased circulating angiotensinogen level', 0.5, 11.397693902282326, 2.387225785538763, 'UPHENO:0068533', 'increased level of protein in blood'),
(626202, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0008602', 'increased circulating interleukin-4 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(626203, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0008608', 'increased circulating interleukin-13 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(626204, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0002968', 'increased circulating alkaline phosphatase level', 0.5063291139240507, 11.397693902282326, 2.4022872963740545, 'UPHENO:0068533', 'increased level of protein in blood'),
(626205, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0005124', 'increased circulating prolactin level', 0.4578313253012048, 11.397693902282326, 2.2843426416935304, 'UPHENO:0068533', 'increased level of protein in blood'),
(626206, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0008644', 'increased circulating interleukin-12a level', 0.449438202247191, 11.397693902282326, 2.2633071062508376, 'UPHENO:0068533', 'increased level of protein in blood'),
(626207, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0005610', 'increased circulating antidiuretic hormone level', 0.4025974025974026, 9.97294124817027, 2.0037665140354677, 'UPHENO:0082534', 'increased bodily fluid base level'),
(626208, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0011009', 'increased circulating glutamate dehydrogenase level', 0.5194805194805194, 11.397693902282326, 2.4332858338546197, 'UPHENO:0068533', 'increased level of protein in blood'),
(626209, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0008626', 'increased circulating interleukin-5 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(626210, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0008641', 'increased circulating interleukin-1 beta level', 0.425531914893617, 11.397693902282326, 2.202290287770779, 'UPHENO:0068533', 'increased level of protein in blood'),
(626211, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0008575', 'increased circulating interferon-beta level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(626212, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0008647', 'increased circulating interleukin-12b level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(626213, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0011714', 'increased circulating interleukin-8 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(626214, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0004731', 'increased circulating gastrin level', 0.5, 11.397693902282326, 2.387225785538763, 'UPHENO:0068533', 'increased level of protein in blood'),
(626215, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0009060', 'increased circulating interleukin-21 level', 0.45454545454545453, 11.397693902282326, 2.2761304785936316, 'UPHENO:0068533', 'increased level of protein in blood'),
(626216, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0005669', 'increased circulating leptin level', 0.5, 11.397693902282326, 2.387225785538763, 'UPHENO:0068533', 'increased level of protein in blood'),
(626217, 'HP:0003538', 'Increased iduronate sulfatase level', 'MP:0011285', 'increased circulating erythropoietin level', 0.475, 11.397693902282326, 2.3267798786271348, 'UPHENO:0068533', 'increased level of protein in blood'),
(626218, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0012144', 'decreased b-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626219, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0020219', 'increased tear production', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626220, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0012031', 'abnormal b-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626221, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0008793', 'abnormal lens epithelium apoptosis', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626222, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0005260', 'ocular hypotension', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626223, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0012038', 'abnormal a-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626224, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0020958', 'abnormal c-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626225, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0013478', 'corneal limbitis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626226, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0005551', 'abnormal eye electrophysiology', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626227, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0012032', 'abnormal ERG latency', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626228, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0006190', 'retina ischemia', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626229, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0012150', 'increased b-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626230, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0020978', 'abnormal FO-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626231, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0011275', 'abnormal behavioral response to light', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626232, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0002638', 'abnormal pupillary reflex', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626233, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0012039', 'abnormal b-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626234, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0020960', 'increased c-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626235, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0012033', 'abnormal ERG implicit time', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626236, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0012149', 'decreased b-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626237, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626238, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0031497', 'increased visual acuity', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626239, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0012154', 'decreased b-wave latency', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626240, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0002090', 'abnormal vision', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626241, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0006194', 'keratoconjunctivitis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626242, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0006072', 'abnormal retina apoptosis', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626243, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0006224', 'oculomotor apraxia', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626244, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0006152', 'tunnel vision', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626245, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626246, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0002001', 'blindness', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626247, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626248, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0005251', 'blepharitis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626249, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0012147', 'increased a-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626250, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0005515', 'uveitis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626251, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0011832', 'abnormal visual acuity', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626252, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0001389', 'abnormal eye movement', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626253, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0012034', 'abnormal a-wave shape', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626254, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0020975', 'abnormal FO-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626255, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0003100', 'myopia', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626256, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0006145', 'legal blindness', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626257, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0014179', 'abnormal blood-retina barrier function', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626258, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0020974', 'abnormal FO-wave shape', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626259, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0012148', 'decreased a-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626260, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0006150', 'double vision', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626261, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0001851', 'eye inflammation', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626262, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0012153', 'increased b-wave latency', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626263, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0008145', 'hemeralopia', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626264, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0001999', 'photosensitivity', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626265, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0010749', 'absent visual evoked potential', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626266, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0003011', 'delayed dark adaptation', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626267, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0013479', 'scleritis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626268, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0012037', 'abnormal b-wave latency', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626269, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0005257', 'abnormal intraocular pressure', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626270, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0006148', 'binocular blindness', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626271, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0020220', 'decreased tear production', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626272, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0012030', 'abnormal a-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626273, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0020860', 'abnormal cornea physiology', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626274, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0020980', 'increased FO-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626275, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0013450', 'abnormal lacrimal apparatus physiology', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626276, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0012152', 'decreased a-wave latency', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626277, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0012050', 'decreased susceptilbility to retina ischemic injury', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626278, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0003096', 'increased corneal light-scattering', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626279, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0020976', 'increased FO-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626280, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0004022', 'abnormal cone electrophysiology', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626281, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0020977', 'decreased FO-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626282, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0014132', 'abnormal tear film physiology', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626283, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0006157', 'palsy of the eye', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626284, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0014157', 'alacrima', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626285, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0013145', 'eye discharge', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626286, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0020961', 'abnormal c-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626287, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0013468', 'chromodacryorrhea', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626288, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0012040', 'abnormal c-wave shape', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626289, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0020962', 'increased c-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626290, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0020439', 'absent b-wave', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626291, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0020979', 'decreased FO-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626292, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0012049', 'increased susceptilbility to retina ischemic injury', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626293, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0012035', 'abnormal b-wave shape', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626294, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0008144', 'nyctalopia', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626295, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0001337', 'dry eyes', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626296, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0012143', 'decreased a-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626297, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0020861', 'abnormal corneal wound healing', 0.45, 8.795504987450572, 1.98946657281613, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626298, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0004021', 'abnormal rod electrophysiology', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626299, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0012146', 'increased b-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626300, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0006203', 'eye hemorrhage', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626301, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0008795', 'abnormal lens fiber apoptosis', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626302, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0012151', 'increased a-wave latency', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626303, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0005253', 'abnormal eye physiology', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626304, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0001852', 'conjunctivitis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626305, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0005258', 'ocular hypertension', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626306, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0020218', 'abnormal tear production', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626307, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0020963', 'decreased c-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626308, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0006149', 'decreased visual acuity', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626309, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0012145', 'increased a-wave amplitude', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626310, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0006153', 'hypermetropia', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626311, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0010748', 'abnormal visual evoked potential', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626312, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0006147', 'monocular blindness', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626313, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0012048', 'abnormal response to retina ischemic injury', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626314, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0003665', 'endophthalmitis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626315, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0006251', 'eyelid apraxia', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626316, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0020959', 'decreased c-wave implicit time', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626317, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0012036', 'abnormal a-wave latency', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626318, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0003101', 'high myopia', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626319, 'HP:0008045', 'Enlarged flash visual evoked potentials', 'MP:0001313', 'increased incidence of corneal inflammation', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(626320, 'HP:0041050', 'Renal tubular cyst', 'MP:0011352', 'proximal convoluted tubule brush border loss', 0.4186046511627907, 10.047451525800549, 2.050831524292717, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(626321, 'HP:0041050', 'Renal tubular cyst', 'MP:0004755', 'abnormal loop of Henle morphology', 0.46153846153846156, 10.047451525800549, 2.1534357012922984, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(626322, 'HP:0041050', 'Renal tubular cyst', 'MP:0011402', 'renal cast', 0.4594594594594595, 8.69825431939161, 1.9991236149444531, 'UPHENO:0076756', 'abnormal nephron morphology'),
(626323, 'HP:0041050', 'Renal tubular cyst', 'MP:0011331', 'abnormal papillary duct morphology', 0.4146341463414634, 8.69825431939161, 1.8991032763864863, 'UPHENO:0076756', 'abnormal nephron morphology'),
(626324, 'HP:0041050', 'Renal tubular cyst', 'MP:0005325', 'abnormal renal glomerulus morphology', 0.40476190476190477, 8.69825431939161, 1.876358704091628, 'UPHENO:0076756', 'abnormal nephron morphology'),
(626325, 'HP:0041050', 'Renal tubular cyst', 'MP:0009860', 'nephrosclerosis', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(626326, 'HP:0041050', 'Renal tubular cyst', 'MP:0011843', 'abnormal kidney collecting duct epithelium morphology', 0.4146341463414634, 8.69825431939161, 1.8991032763864863, 'UPHENO:0076756', 'abnormal nephron morphology'),
(626327, 'HP:0041050', 'Renal tubular cyst', 'MP:0002828', 'abnormal renal glomerular capsule morphology', 0.40476190476190477, 8.69825431939161, 1.876358704091628, 'UPHENO:0076756', 'abnormal nephron morphology'),
(626328, 'HP:0041050', 'Renal tubular cyst', 'MP:0003014', 'abnormal kidney medulla morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(626329, 'HP:0041050', 'Renal tubular cyst', 'MP:0012026', 'abnormal S-shaped body morphology', 0.4358974358974359, 8.69825431939161, 1.94718945010664, 'UPHENO:0076756', 'abnormal nephron morphology'),
(626330, 'HP:0041050', 'Renal tubular cyst', 'MP:0004756', 'abnormal proximal convoluted tubule morphology', 0.43902439024390244, 10.047451525800549, 2.1002562414190686, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(626331, 'HP:0041050', 'Renal tubular cyst', 'MP:0011425', 'abnormal kidney interstitium morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(626332, 'HP:0041050', 'Renal tubular cyst', 'MP:0004969', 'pale kidney', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(626333, 'HP:0041050', 'Renal tubular cyst', 'MP:0011344', 'abnormal loop of Henle ascending limb thick segment morphology', 0.4186046511627907, 10.047451525800549, 2.050831524292717, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(626334, 'HP:0041050', 'Renal tubular cyst', 'MP:0011289', 'abnormal nephron number', 0.40476190476190477, 8.69825431939161, 1.876358704091628, 'UPHENO:0076756', 'abnormal nephron morphology'),
(626335, 'HP:0041050', 'Renal tubular cyst', 'MP:0011341', 'abnormal loop of Henle descending limb morphology', 0.43902439024390244, 10.047451525800549, 2.1002562414190686, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(626336, 'HP:0041050', 'Renal tubular cyst', 'MP:0000527', 'abnormal kidney development', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(626337, 'HP:0041050', 'Renal tubular cyst', 'MP:0003881', 'abnormal nephron morphology', 0.4722222222222222, 8.69825431939161, 2.026699036403074, 'UPHENO:0076756', 'abnormal nephron morphology'),
(626338, 'HP:0041050', 'Renal tubular cyst', 'MP:0011350', 'abnormal proximal convoluted tubule brush border morphology', 0.42857142857142855, 10.047451525800549, 2.075102564673496, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(626339, 'HP:0041050', 'Renal tubular cyst', 'MP:0012025', 'abnormal comma shaped body morphology', 0.4358974358974359, 8.69825431939161, 1.94718945010664, 'UPHENO:0076756', 'abnormal nephron morphology'),
(626340, 'HP:0041050', 'Renal tubular cyst', 'MP:0011381', 'abnormal kidney lobe morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(626341, 'HP:0041050', 'Renal tubular cyst', 'MP:0002135', 'abnormal kidney morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(626342, 'HP:0041050', 'Renal tubular cyst', 'MP:0004754', 'abnormal kidney collecting duct morphology', 0.4358974358974359, 8.69825431939161, 1.94718945010664, 'UPHENO:0076756', 'abnormal nephron morphology'),
(626343, 'HP:0041050', 'Renal tubular cyst', 'MP:0011383', 'abnormal kidney capsule morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(626344, 'HP:0041050', 'Renal tubular cyst', 'MP:0011342', 'abnormal loop of Henle ascending limb morphology', 0.43902439024390244, 10.047451525800549, 2.1002562414190686, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(626345, 'HP:0041050', 'Renal tubular cyst', 'MP:0011351', 'absent proximal convoluted tubule brush border', 0.4186046511627907, 10.047451525800549, 2.050831524292717, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(626346, 'HP:0041050', 'Renal tubular cyst', 'MP:0004757', 'abnormal distal convoluted tubule morphology', 0.43902439024390244, 10.047451525800549, 2.1002562414190686, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(626347, 'HP:0041050', 'Renal tubular cyst', 'MP:0011376', 'abnormal kidney corticomedullary boundary morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(626348, 'HP:0041050', 'Renal tubular cyst', 'MP:0002827', 'abnormal renal corpuscle morphology', 0.425, 8.69825431939161, 1.9226955260106666, 'UPHENO:0076756', 'abnormal nephron morphology'),
(626349, 'HP:0041050', 'Renal tubular cyst', 'MP:0004194', 'abnormal kidney pelvis morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(626350, 'HP:0041050', 'Renal tubular cyst', 'MP:0004967', 'abnormal kidney epithelium morphology', 0.45714285714285713, 8.472720947690348, 1.9680558584047614, 'UPHENO:0087993', 'abnormal kidney epithelium morphology'),
(626351, 'HP:0041050', 'Renal tubular cyst', 'MP:0011534', 'granular kidney', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(626352, 'HP:0041050', 'Renal tubular cyst', 'MP:0009640', 'abnormal renal tubule epithelium morphology', 0.46153846153846156, 10.047451525800549, 2.1534357012922984, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(626353, 'HP:0041050', 'Renal tubular cyst', 'MP:0012024', 'abnormal nephron morphogenesis', 0.4594594594594595, 8.69825431939161, 1.9991236149444531, 'UPHENO:0076756', 'abnormal nephron morphology'),
(626354, 'HP:0041050', 'Renal tubular cyst', 'MP:0000521', 'abnormal kidney cortex morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(626355, 'HP:0041050', 'Renal tubular cyst', 'MP:0002703', 'abnormal renal tubule morphology', 0.4864864864864865, 10.047451525800549, 2.2108707313929497, 'UPHENO:0076714', 'abnormal nephron tubule morphology'),
(626356, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0001213', 'abnormal skin cell number', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626357, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0005421', 'loose skin', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626358, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0000428', 'abnormal craniofacial morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626359, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0013406', 'abnormal epidermal immune compartment', 0.44, 6.904974582545727, 1.743040107490393, 'UPHENO:0003811', 'abnormal skin of body'),
(626360, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0004241', 'acantholysis', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(626361, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0002796', 'impaired skin barrier function', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(626362, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0030574', 'increased hair follicle cell proliferation', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(626363, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626364, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0012078', 'abnormal tail ring morphology', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626365, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0002109', 'abnormal limb morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626366, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0005500', 'abnormal gustatory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626367, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0000462', 'abnormal digestive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626368, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0001246', 'mixed cellular infiltration to dermis', 0.44, 6.904974582545727, 1.743040107490393, 'UPHENO:0003811', 'abnormal skin of body'),
(626369, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0030575', 'decreased hair follicle cell proliferation', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(626370, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0009827', 'skin detachment', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626371, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0011239', 'abnormal skin coloration', 0.4782608695652174, 6.904974582545727, 1.8172449334566994, 'UPHENO:0003811', 'abnormal skin of body'),
(626372, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0009602', 'abnormal keratohyalin granule morphology', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(626373, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0002897', 'blotchy skin', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626374, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0000405', 'abnormal auchene hair morphology', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(626375, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626376, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0010072', 'increased pruritus', 0.44, 6.904974582545727, 1.743040107490393, 'UPHENO:0003811', 'abnormal skin of body'),
(626377, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0009931', 'abnormal skin appearance', 0.4782608695652174, 6.904974582545727, 1.8172449334566994, 'UPHENO:0003811', 'abnormal skin of body'),
(626378, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0011159', 'abnormal epidermal-dermal junction morphology', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626379, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0009545', 'abnormal dermis papillary layer morphology', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(626380, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0001198', 'tight skin', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626381, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0002095', 'abnormal skin pigmentation', 0.44, 6.904974582545727, 1.743040107490393, 'UPHENO:0003811', 'abnormal skin of body'),
(626382, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0000407', 'abnormal duvet hair morphology', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(626383, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0001209', 'spontaneous skin ulceration', 0.44, 6.904974582545727, 1.743040107490393, 'UPHENO:0003811', 'abnormal skin of body'),
(626384, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0001192', 'scaly skin', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626385, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0001193', 'psoriasis', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626386, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626387, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0008418', 'abnormal cutaneous elastic fiber morphology', 0.44, 6.904974582545727, 1.743040107490393, 'UPHENO:0003811', 'abnormal skin of body'),
(626388, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0010678', 'abnormal skin adnexa morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626389, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0010233', 'hairless tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626390, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0009387', 'abnormal epidermal pigmentation', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(626391, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0010232', 'delayed skin pigmentation appearance', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(626392, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0009379', 'abnormal foot pigmentation', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(626393, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0002163', 'abnormal gland morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626394, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0010206', 'pigment incontinence', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(626395, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0002060', 'abnormal skin morphology', 0.5, 6.904974582545727, 1.8580869977675598, 'UPHENO:0003811', 'abnormal skin of body'),
(626396, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0000003', 'abnormal adipose tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626397, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0008438', 'abnormal cutaneous collagen fibril morphology', 0.44, 6.904974582545727, 1.743040107490393, 'UPHENO:0003811', 'abnormal skin of body'),
(626398, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626399, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0004134', 'abnormal chest morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626400, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0003853', 'dry skin', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626401, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0003941', 'abnormal skin development', 0.4782608695652174, 6.904974582545727, 1.8172449334566994, 'UPHENO:0003811', 'abnormal skin of body'),
(626402, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626403, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0000397', 'abnormal guard hair morphology', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(626404, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0013332', 'peliosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626405, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0001236', 'abnormal epidermis stratum spinosum morphology', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(626406, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0003652', 'abnormal skin turgor', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626407, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0020973', 'abnormal gland development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626408, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0031310', 'abnormal cyst', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626409, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0000367', 'abnormal coat/ hair morphology', 0.44, 6.904974582545727, 1.743040107490393, 'UPHENO:0003811', 'abnormal skin of body'),
(626410, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0005508', 'abnormal skeleton morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626411, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0001239', 'abnormal epidermis stratum granulosum morphology', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(626412, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0003384', 'abnormal ventral body wall morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626413, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0003653', 'decreased skin turgor', 0.44, 6.904974582545727, 1.743040107490393, 'UPHENO:0003811', 'abnormal skin of body'),
(626414, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0001216', 'abnormal epidermal layer morphology', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626415, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0008854', 'bleb', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626416, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0001230', 'epidermal desquamation', 0.44, 6.904974582545727, 1.743040107490393, 'UPHENO:0003811', 'abnormal skin of body'),
(626417, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0008816', 'petechiae', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626418, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0005499', 'abnormal olfactory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626419, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0001510', 'abnormal coat appearance', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(626420, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0009441', 'delayed skin barrier formation', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626421, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0001233', 'abnormal epidermis suprabasal layer morphology', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(626422, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0009385', 'abnormal dermal pigmentation', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(626423, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0010073', 'decreased pruritus', 0.44, 6.904974582545727, 1.743040107490393, 'UPHENO:0003811', 'abnormal skin of body'),
(626424, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0001210', 'skin ridges', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626425, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0003089', 'decreased skin tensile strength', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(626426, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0001195', 'flaky skin', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626427, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0003717', 'pallor', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626428, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0031103', 'skin rash', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626429, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0003279', 'aneurysm', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626430, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0001208', 'blistering', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626431, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626432, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0001196', 'shiny skin', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626433, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0030573', 'abnormal hair follicle cell proliferation', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(626434, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626435, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0002111', 'abnormal tail morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626436, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0006281', 'abnormal tail development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626437, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0010016', 'variable depigmentation', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(626438, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0000400', 'abnormal awl hair morphology', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(626439, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0002108', 'abnormal muscle morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626440, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0009610', 'abnormal epidermis stratum lucidum morphology', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(626441, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0010071', 'abnormal pruritus', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626442, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0011194', 'abnormal hair follicle physiology', 0.44, 6.904974582545727, 1.743040107490393, 'UPHENO:0003811', 'abnormal skin of body'),
(626443, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0014134', 'abnormal embryo morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626444, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0008856', 'fetal bleb', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626445, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0000685', 'abnormal immune system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626446, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0011515', 'purpura', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626447, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0001243', 'abnormal dermal layer morphology', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626448, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0003385', 'abnormal body wall morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626449, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0011160', 'dermal-epidermal separation', 0.44, 6.904974582545727, 1.743040107490393, 'UPHENO:0003811', 'abnormal skin of body'),
(626450, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0005275', 'abnormal skin tensile strength', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626451, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626452, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0003705', 'abnormal hypodermis morphology', 0.43478260869565216, 6.509554027552121, 1.6823319772103247, 'UPHENO:0002635', 'abnormal integument'),
(626453, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0002132', 'abnormal respiratory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626454, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0001212', 'skin lesions', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626455, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0003940', 'abnormal dermatome morphology', 0.44, 6.904974582545727, 1.743040107490393, 'UPHENO:0003811', 'abnormal skin of body'),
(626456, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0013113', 'greasy tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626457, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0002160', 'abnormal reproductive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626458, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0001231', 'abnormal epidermis stratum basale morphology', 0.4230769230769231, 6.904974582545727, 1.7091914463593034, 'UPHENO:0003811', 'abnormal skin of body'),
(626459, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0020982', 'abnormal skin adnexa development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626460, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0008923', 'thoracoschisis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626461, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0009473', 'abnormal skin exfoliation', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626462, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0005501', 'abnormal skin physiology', 0.4782608695652174, 6.904974582545727, 1.8172449334566994, 'UPHENO:0003811', 'abnormal skin of body'),
(626463, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0013118', 'swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626464, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0008419', 'abnormal cutaneous microfibril morphology', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(626465, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0000402', 'abnormal zigzag hair morphology', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(626466, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0009563', 'dyskeratosis', 0.4782608695652174, 6.904974582545727, 1.8172449334566994, 'UPHENO:0003811', 'abnormal skin of body'),
(626467, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0001201', 'translucent skin', 0.4583333333333333, 6.904974582545727, 1.7789828602322522, 'UPHENO:0003811', 'abnormal skin of body'),
(626468, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0002925', 'abnormal cardiovascular development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626469, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0003632', 'abnormal nervous system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(626470, 'HP:0031285', 'Abnormal perifollicular morphology', 'MP:0001191', 'abnormal skin condition', 0.4782608695652174, 6.904974582545727, 1.8172449334566994, 'UPHENO:0003811', 'abnormal skin of body'),
(626471, 'HP:0007634', 'Nonarteritic anterior ischemic optic neuropathy', 'MP:0006186', 'retina fibrosis', 0.40625, 9.356059413574362, 1.9495894790351596, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(626472, 'HP:0007634', 'Nonarteritic anterior ischemic optic neuropathy', 'MP:0006188', 'calcified retina', 0.40298507462686567, 9.356059413574362, 1.94173950389661, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(626473, 'HP:0003219', 'Ethylmalonic aciduria', 'MP:0003311', 'aminoaciduria', 0.42105263157894735, 10.47786425096631, 2.1004124157403803, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(626474, 'HP:0003219', 'Ethylmalonic aciduria', 'MP:0011517', 'hyperoxaluria', 0.4657534246575342, 12.732678149995134, 2.435218358468577, 'UPHENO:0068078', 'increased level of dicarboxylic acid in urine'),
(626475, 'HP:0003219', 'Ethylmalonic aciduria', 'MP:0002931', 'glutaricadicuria', 0.5492957746478874, 12.732678149995134, 2.6446183671266836, 'UPHENO:0068078', 'increased level of dicarboxylic acid in urine'),
(626476, 'HP:0003219', 'Ethylmalonic aciduria', 'MP:0030613', 'dicarboxylic aciduria', 0.5151515151515151, 12.732678149995134, 2.561104925790153, 'UPHENO:0068078', 'increased level of dicarboxylic acid in urine'),
(626477, 'HP:0003219', 'Ethylmalonic aciduria', 'MP:0030615', 'ethylmalonic aciduria', 0.5942028985507246, 16.607147267911277, 3.1413396892490995, 'UPHENO:0068264', 'increased level of ethylmalonic acid in urine'),
(626478, 'HP:0003219', 'Ethylmalonic aciduria', 'MP:0030614', 'methylmalonic aciduria', 0.47297297297297297, 12.732678149995134, 2.4540196899192175, 'UPHENO:0068078', 'increased level of dicarboxylic acid in urine'),
(626479, 'HP:0003219', 'Ethylmalonic aciduria', 'MP:0030618', 'tryptophanuria', 0.4074074074074074, 10.47786425096631, 2.066097652496837, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(626480, 'HP:0003219', 'Ethylmalonic aciduria', 'MP:0020400', 'cystinuria', 0.4074074074074074, 10.47786425096631, 2.066097652496837, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(626481, 'HP:0003219', 'Ethylmalonic aciduria', 'MP:0011654', 'histidinuria', 0.4074074074074074, 10.47786425096631, 2.066097652496837, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(626482, 'HP:0003219', 'Ethylmalonic aciduria', 'MP:0011765', 'oroticaciduria', 0.4714285714285714, 10.47786425096631, 2.2225131215485647, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(626483, 'HP:0003219', 'Ethylmalonic aciduria', 'MP:0011516', 'aspartylglucosaminuria', 0.4155844155844156, 10.47786425096631, 2.086728801572134, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(626484, 'HP:0010592', 'Abnormality of the distal tibial epiphysis', 'MP:0002764', 'short tibia', 0.4125, 12.548253578857707, 2.275116392908021, 'UPHENO:0020975', 'abnormal tibia morphology'),
(626485, 'HP:0010592', 'Abnormality of the distal tibial epiphysis', 'MP:0004357', 'long tibia', 0.4125, 12.548253578857707, 2.275116392908021, 'UPHENO:0020975', 'abnormal tibia morphology'),
(626486, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0004477', 'turbinate hypoplasia', 0.43243243243243246, 10.555485148088783, 2.136477034300263, 'UPHENO:0081792', 'bone element hypoplasia in independent continuant'),
(626487, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0000071', 'axial skeleton hypoplasia', 0.4074074074074074, 8.202005804774931, 1.8279928666337462, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(626488, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0004385', 'interparietal bone hypoplasia', 0.4264705882352941, 10.555485148088783, 2.1216983669255, 'UPHENO:0081792', 'bone element hypoplasia in independent continuant'),
(626489, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0000460', 'mandible hypoplasia', 0.4358974358974359, 12.49167005049134, 2.333471007980594, 'UPHENO:0081788', 'bone element hypoplasia in face'),
(626490, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0030386', 'facial bone hypoplasia', 0.5396825396825397, 12.49167005049134, 2.5964468447718096, 'UPHENO:0081788', 'bone element hypoplasia in face'),
(626491, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0009912', 'decreased hyoid bone size', 0.42424242424242425, 8.103321529915524, 1.854123180985339, 'UPHENO:0084457', 'abnormal facial skeleton morphology'),
(626492, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0004871', 'premaxilla hypoplasia', 0.40476190476190477, 12.49167005049134, 2.248588927148338, 'UPHENO:0081788', 'bone element hypoplasia in face'),
(626493, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0030377', 'zygomatic arch hypoplasia', 0.4927536231884058, 12.49167005049134, 2.4809908659754685, 'UPHENO:0081788', 'bone element hypoplasia in face'),
(626494, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0004377', 'small frontal bone', 0.417910447761194, 8.103321529915524, 1.8402344222734017, 'UPHENO:0084457', 'abnormal facial skeleton morphology'),
(626495, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0030303', 'small ethmoid bone', 0.4057971014492754, 8.103321529915524, 1.813368244166426, 'UPHENO:0084457', 'abnormal facial skeleton morphology'),
(626496, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0030056', 'lacrimal bone hypoplasia', 0.4533333333333333, 12.49167005049134, 2.3796828408192146, 'UPHENO:0081788', 'bone element hypoplasia in face'),
(626497, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0004450', 'presphenoid bone hypoplasia', 0.4657534246575342, 12.49167005049134, 2.4120609664161257, 'UPHENO:0081788', 'bone element hypoplasia in face'),
(626498, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0004461', 'basisphenoid bone hypoplasia', 0.4533333333333333, 12.49167005049134, 2.3796828408192146, 'UPHENO:0081788', 'bone element hypoplasia in face'),
(626499, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0030112', 'zygomatic bone hypoplasia', 0.43037974683544306, 12.49167005049134, 2.3186551692484048, 'UPHENO:0081788', 'bone element hypoplasia in face'),
(626500, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0004460', 'alisphenoid bone hypoplasia', 0.4533333333333333, 12.49167005049134, 2.3796828408192146, 'UPHENO:0081788', 'bone element hypoplasia in face'),
(626501, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0030027', 'basioccipital bone hypoplasia', 0.4084507042253521, 10.555485148088783, 2.076389978346339, 'UPHENO:0081792', 'bone element hypoplasia in independent continuant'),
(626502, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0030384', 'short facial bone', 0.42424242424242425, 8.103321529915524, 1.854123180985339, 'UPHENO:0084457', 'abnormal facial skeleton morphology'),
(626503, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0000457', 'maxilla hypoplasia', 0.41975308641975306, 12.49167005049134, 2.2898508812215117, 'UPHENO:0081788', 'bone element hypoplasia in face'),
(626504, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0030286', 'occipital bone hypoplasia', 0.43283582089552236, 10.555485148088783, 2.137473293171988, 'UPHENO:0081792', 'bone element hypoplasia in independent continuant'),
(626505, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0004869', 'frontal bone hypoplasia', 0.4788732394366197, 12.49167005049134, 2.4457977232494494, 'UPHENO:0081788', 'bone element hypoplasia in face'),
(626506, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0030065', 'face hypoplasia', 0.4098360655737705, 8.202005804774931, 1.8334333336236104, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(626507, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0030383', 'small presphenoid bone', 0.4057971014492754, 8.103321529915524, 1.813368244166426, 'UPHENO:0084457', 'abnormal facial skeleton morphology'),
(626508, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0004424', 'temporal bone hypoplasia', 0.43283582089552236, 10.555485148088783, 2.137473293171988, 'UPHENO:0081792', 'bone element hypoplasia in independent continuant'),
(626509, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0030198', 'nasal septum hypoplasia', 0.41025641025641024, 10.879226813348076, 2.1126458621381548, 'UPHENO:0081786', 'anatomical entity hypoplasia in face'),
(626510, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0013395', 'eyelid hypoplasia', 0.41935483870967744, 10.879226813348076, 2.135943914431645, 'UPHENO:0081786', 'anatomical entity hypoplasia in face'),
(626511, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0004420', 'parietal bone hypoplasia', 0.42028985507246375, 10.555485148088783, 2.106267628557629, 'UPHENO:0081792', 'bone element hypoplasia in independent continuant'),
(626512, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0009899', 'hyoid bone hypoplasia', 0.4857142857142857, 12.49167005049134, 2.4632057559109706, 'UPHENO:0081788', 'bone element hypoplasia in face'),
(626513, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0000103', 'nasal bone hypoplasia', 0.44155844155844154, 12.49167005049134, 2.3485745378755207, 'UPHENO:0081788', 'bone element hypoplasia in face'),
(626514, 'HP:0002692', 'Hypoplastic facial bones', 'MP:0030122', 'temporal bone squamous part hypoplasia', 0.4142857142857143, 10.555485148088783, 2.0911687412086595, 'UPHENO:0081792', 'bone element hypoplasia in independent continuant'),
(626515, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626516, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626517, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626518, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626519, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626520, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626521, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626522, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626523, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626524, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626525, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626526, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626527, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626528, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626529, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626530, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626531, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626532, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626533, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626534, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626535, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626536, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626537, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626538, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626539, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626540, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626541, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626542, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626543, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626544, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626545, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626546, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626547, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626548, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626549, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626550, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626551, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626552, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626553, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626554, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626555, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626556, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626557, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626558, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626559, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626560, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626561, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626562, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626563, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626564, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626565, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626566, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626567, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626568, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626569, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626570, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626571, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626572, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626573, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626574, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626575, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626576, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626577, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626578, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626579, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626580, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626581, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626582, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626583, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626584, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626585, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626586, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626587, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626588, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626589, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626590, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626591, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626592, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626593, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626594, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626595, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626596, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626597, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626598, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626599, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626600, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626601, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626602, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626603, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626604, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626605, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626606, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626607, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626608, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626609, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626610, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626611, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626612, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626613, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626614, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626615, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626616, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626617, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626618, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626619, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626620, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626621, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626622, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626623, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626624, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626625, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626626, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626627, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626628, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626629, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626630, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626631, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626632, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626633, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626634, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626635, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626636, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626637, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626638, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626639, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626640, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626641, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626642, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626643, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626644, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626645, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626646, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626647, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626648, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626649, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626650, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626651, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626652, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626653, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626654, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626655, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626656, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626657, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626658, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626659, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626660, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626661, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626662, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626663, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626664, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626665, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626666, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626667, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626668, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626669, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626670, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626671, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626672, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626673, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626674, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626675, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626676, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626677, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626678, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626679, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626680, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626681, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626682, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626683, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626684, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626685, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626686, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626687, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626688, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626689, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626690, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626691, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626692, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626693, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626694, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626695, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626696, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626697, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626698, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626699, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626700, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626701, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626702, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626703, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626704, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626705, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626706, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626707, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626708, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626709, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626710, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626711, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626712, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626713, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626714, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626715, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626716, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626717, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626718, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626719, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626720, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626721, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626722, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626723, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626724, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626725, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626726, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626727, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626728, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626729, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626730, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626731, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626732, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626733, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626734, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626735, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626736, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626737, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626738, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626739, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626740, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626741, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626742, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626743, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626744, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626745, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626746, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626747, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626748, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626749, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626750, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626751, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626752, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626753, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626754, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626755, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626756, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626757, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626758, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626759, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626760, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626761, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626762, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626763, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626764, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626765, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626766, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626767, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626768, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626769, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626770, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626771, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626772, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626773, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626774, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626775, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626776, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626777, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626778, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626779, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626780, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626781, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626782, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626783, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626784, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626785, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626786, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626787, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626788, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626789, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626790, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626791, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626792, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626793, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626794, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626795, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626796, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626797, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626798, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626799, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626800, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626801, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626802, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626803, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626804, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626805, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626806, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626807, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626808, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626809, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626810, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626811, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626812, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626813, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626814, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626815, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626816, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626817, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626818, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626819, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626820, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626821, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626822, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626823, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626824, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626825, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626826, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626827, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626828, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626829, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626830, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626831, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626832, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626833, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626834, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626835, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626836, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626837, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626838, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626839, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626840, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626841, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626842, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626843, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626844, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626845, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626846, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626847, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626848, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626849, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626850, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626851, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626852, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626853, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626854, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626855, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626856, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626857, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626858, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626859, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626860, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626861, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626862, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626863, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626864, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626865, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626866, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626867, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626868, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626869, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626870, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626871, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626872, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626873, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626874, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626875, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626876, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626877, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626878, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626879, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626880, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626881, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626882, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626883, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626884, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626885, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626886, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626887, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626888, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626889, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626890, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626891, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626892, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626893, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626894, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626895, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626896, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626897, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626898, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626899, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626900, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626901, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626902, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626903, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626904, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626905, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626906, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626907, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626908, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626909, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626910, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626911, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626912, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626913, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626914, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626915, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626916, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626917, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626918, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626919, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626920, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626921, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626922, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626923, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626924, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626925, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626926, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626927, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626928, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626929, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626930, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626931, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626932, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626933, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626934, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626935, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626936, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626937, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626938, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626939, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626940, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626941, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626942, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626943, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626944, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626945, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626946, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626947, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626948, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626949, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626950, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626951, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626952, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626953, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626954, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626955, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626956, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626957, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626958, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626959, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626960, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626961, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626962, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626963, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626964, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626965, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626966, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626967, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626968, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626969, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626970, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626971, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626972, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626973, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626974, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626975, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626976, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626977, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626978, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626979, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626980, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626981, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626982, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626983, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626984, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626985, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626986, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626987, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626988, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626989, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626990, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626991, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626992, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626993, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626994, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626995, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626996, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(626997, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626998, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(626999, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627000, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627001, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627002, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627003, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627004, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627005, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627006, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627007, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627008, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627009, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627010, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627011, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627012, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627013, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627014, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627015, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627016, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627017, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627018, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627019, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627020, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627021, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627022, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627023, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627024, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627025, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627026, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627027, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627028, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627029, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627030, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627031, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627032, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627033, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627034, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627035, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627036, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627037, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627038, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627039, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627040, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627041, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627042, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627043, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627044, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627045, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627046, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627047, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627048, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627049, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627050, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627051, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627052, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627053, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627054, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627055, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627056, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627057, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627058, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627059, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627060, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627061, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627062, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627063, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627064, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627065, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627066, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627067, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627068, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627069, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627070, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627071, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627072, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627073, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627074, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627075, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627076, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627077, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627078, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627079, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627080, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627081, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627082, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627083, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627084, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627085, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627086, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627087, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627088, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627089, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627090, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627091, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627092, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627093, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627094, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627095, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627096, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627097, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627098, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627099, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627100, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627101, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627102, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627103, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627104, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627105, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627106, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627107, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627108, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627109, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627110, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627111, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627112, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627113, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627114, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627115, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627116, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627117, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627118, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627119, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627120, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627121, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627122, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627123, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627124, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627125, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627126, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627127, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627128, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627129, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627130, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627131, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627132, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627133, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627134, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627135, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627136, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627137, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627138, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627139, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627140, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627141, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627142, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627143, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627144, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627145, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627146, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627147, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627148, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627149, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627150, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627151, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627152, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627153, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627154, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627155, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627156, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627157, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627158, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627159, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627160, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627161, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627162, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627163, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627164, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627165, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627166, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627167, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627168, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627169, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627170, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627171, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627172, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627173, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627174, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627175, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627176, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627177, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627178, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627179, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627180, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627181, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627182, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627183, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627184, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627185, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627186, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627187, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627188, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627189, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627190, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627191, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627192, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627193, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627194, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627195, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627196, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627197, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627198, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627199, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627200, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627201, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627202, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627203, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627204, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627205, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627206, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627207, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627208, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627209, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627210, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627211, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627212, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627213, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627214, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627215, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627216, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627217, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627218, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627219, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627220, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627221, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627222, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627223, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627224, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627225, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627226, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627227, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627228, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627229, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627230, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627231, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627232, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627233, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627234, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627235, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627236, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627237, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627238, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627239, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627240, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627241, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627242, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627243, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627244, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627245, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627246, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627247, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627248, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627249, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627250, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627251, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627252, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627253, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627254, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627255, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627256, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627257, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627258, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627259, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627260, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627261, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627262, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627263, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(627264, 'HP:5000046', 'Anti-Lrp4 antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627265, 'HP:0003287', 'Abnormality of mitochondrial metabolism', 'MP:0013258', 'abnormal extracellular matrix morphology', 0.44, 6.910179741676988, 1.7436969594335692, 'UPHENO:0006889', 'abnormal cellular_component'),
(627266, 'HP:0003287', 'Abnormality of mitochondrial metabolism', 'MP:0004272', 'abnormal basement membrane morphology', 0.4074074074074074, 6.910179741676988, 1.6778731815235053, 'UPHENO:0006889', 'abnormal cellular_component'),
(627267, 'HP:0011531', 'Vitritis', 'MP:0006225', 'ocular rupture', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(627268, 'HP:0011531', 'Vitritis', 'MP:0005195', 'abnormal posterior eye segment morphology', 0.40816326530612246, 7.832360208310102, 1.7879825831583462, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(627269, 'HP:0011531', 'Vitritis', 'MP:0006200', 'vitreous body deposition', 0.4230769230769231, 7.832360208310102, 1.820354596599785, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(627270, 'HP:0011531', 'Vitritis', 'MP:0002697', 'abnormal eye size', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(627271, 'HP:0011531', 'Vitritis', 'MP:0005176', 'eyelids fail to open', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(627272, 'HP:0011531', 'Vitritis', 'MP:0002700', 'increased opacity of vitreous body', 0.4074074074074074, 7.832360208310102, 1.786326276565555, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(627273, 'HP:0011531', 'Vitritis', 'MP:0003381', 'vitreal fibroplasia', 0.4230769230769231, 7.832360208310102, 1.820354596599785, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(627274, 'HP:0011531', 'Vitritis', 'MP:0002699', 'abnormal vitreous body morphology', 0.43137254901960786, 7.832360208310102, 1.8381145742032718, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(627275, 'HP:0011531', 'Vitritis', 'MP:0006209', 'calcified intraocular region', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(627276, 'HP:0011531', 'Vitritis', 'MP:0001289', 'persistence of hyaloid vascular system', 0.41509433962264153, 7.832360208310102, 1.803099661237597, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(627277, 'HP:0033539', 'Bilateral apical pulmonary fibrosis', 'MP:0002311', 'abnormal inspiratory capacity', 0.46511627906976744, 9.915985363358194, 2.1475768241242124, 'UPHENO:0019970', 'abnormal lung morphology'),
(627278, 'HP:0033539', 'Bilateral apical pulmonary fibrosis', 'MP:0003426', 'pulmonary interstitial fibrosis', 0.4523809523809524, 15.607147267911275, 2.657136832195038, 'UPHENO:0076299', 'lung fibrosis'),
(627279, 'HP:0033539', 'Bilateral apical pulmonary fibrosis', 'MP:0002312', 'abnormal inspiratory reserve volume', 0.46511627906976744, 9.915985363358194, 2.1475768241242124, 'UPHENO:0019970', 'abnormal lung morphology'),
(627280, 'HP:0033539', 'Bilateral apical pulmonary fibrosis', 'MP:0004881', 'abnormal lung size', 0.4358974358974359, 9.915985363358194, 2.079026838278992, 'UPHENO:0019970', 'abnormal lung morphology'),
(627281, 'HP:0033539', 'Bilateral apical pulmonary fibrosis', 'MP:0002313', 'abnormal tidal volume', 0.46511627906976744, 9.915985363358194, 2.1475768241242124, 'UPHENO:0019970', 'abnormal lung morphology'),
(627282, 'HP:0033539', 'Bilateral apical pulmonary fibrosis', 'MP:0010857', 'pulmonary necrosis', 0.4222222222222222, 9.915985363358194, 2.046154778026366, 'UPHENO:0019970', 'abnormal lung morphology'),
(627283, 'HP:0033539', 'Bilateral apical pulmonary fibrosis', 'MP:0002306', 'abnormal functional residual capacity', 0.46511627906976744, 9.915985363358194, 2.1475768241242124, 'UPHENO:0019970', 'abnormal lung morphology'),
(627284, 'HP:0033539', 'Bilateral apical pulmonary fibrosis', 'MP:0005629', 'abnormal lung weight', 0.40476190476190477, 9.915985363358194, 2.00340039015271, 'UPHENO:0019970', 'abnormal lung morphology'),
(627285, 'HP:0033539', 'Bilateral apical pulmonary fibrosis', 'MP:0001942', 'abnormal lung volume', 0.47619047619047616, 9.915985363358194, 2.172992819149509, 'UPHENO:0019970', 'abnormal lung morphology'),
(627286, 'HP:0033539', 'Bilateral apical pulmonary fibrosis', 'MP:0002337', 'abnormal whole-body plethysmography', 0.46511627906976744, 9.915985363358194, 2.1475768241242124, 'UPHENO:0019970', 'abnormal lung morphology'),
(627287, 'HP:0033539', 'Bilateral apical pulmonary fibrosis', 'MP:0005585', 'increased tidal volume', 0.45454545454545453, 9.915985363358194, 2.123032282904272, 'UPHENO:0019970', 'abnormal lung morphology'),
(627288, 'HP:0033539', 'Bilateral apical pulmonary fibrosis', 'MP:0002309', 'abnormal vital capacity', 0.46511627906976744, 9.915985363358194, 2.1475768241242124, 'UPHENO:0019970', 'abnormal lung morphology'),
(627289, 'HP:0033539', 'Bilateral apical pulmonary fibrosis', 'MP:0005586', 'decreased tidal volume', 0.45454545454545453, 9.915985363358194, 2.123032282904272, 'UPHENO:0019970', 'abnormal lung morphology'),
(627290, 'HP:0033539', 'Bilateral apical pulmonary fibrosis', 'MP:0002308', 'abnormal residual volume', 0.46511627906976744, 9.915985363358194, 2.1475768241242124, 'UPHENO:0019970', 'abnormal lung morphology'),
(627291, 'HP:0033539', 'Bilateral apical pulmonary fibrosis', 'MP:0002304', 'abnormal total lung capacity', 0.45454545454545453, 9.915985363358194, 2.123032282904272, 'UPHENO:0019970', 'abnormal lung morphology'),
(627292, 'HP:0033539', 'Bilateral apical pulmonary fibrosis', 'MP:0010938', 'decreased total lung capacity', 0.4444444444444444, 9.915985363358194, 2.099310507270655, 'UPHENO:0019970', 'abnormal lung morphology'),
(627293, 'HP:0033539', 'Bilateral apical pulmonary fibrosis', 'MP:0006050', 'pulmonary fibrosis', 0.5135135135135135, 15.607147267911275, 2.830985875886341, 'UPHENO:0076299', 'lung fibrosis'),
(627294, 'HP:0033539', 'Bilateral apical pulmonary fibrosis', 'MP:0010937', 'increased total lung capacity', 0.4444444444444444, 9.915985363358194, 2.099310507270655, 'UPHENO:0019970', 'abnormal lung morphology'),
(627295, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627296, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0009046', 'muscle twitch', 0.4827586206896552, 9.83016599489719, 2.178439206598825, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627297, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4827586206896552, 9.83016599489719, 2.178439206598825, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627298, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0009410', 'abnormal skeletal muscle satellite cell proliferation', 0.4117647058823529, 9.83016599489719, 2.011893488647833, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627299, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0030946', 'abnormal myoblast proliferation', 0.40540540540540543, 7.206267831629091, 1.7092278758964596, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(627300, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0000751', 'myopathy', 0.4827586206896552, 9.83016599489719, 2.178439206598825, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627301, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0010680', 'abnormal skin adnexa physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627302, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0020381', 'muscle gating pore current', 0.4666666666666667, 9.83016599489719, 2.14182417523444, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627303, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0004130', 'abnormal muscle cell glucose uptake', 0.4117647058823529, 9.83016599489719, 2.011893488647833, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627304, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0000732', 'delayed primary myocyte appearance', 0.4166666666666667, 7.206267831629091, 1.7328045465407, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(627305, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0000740', 'impaired smooth muscle contractility', 0.45161290322580644, 9.83016599489719, 2.106995444738103, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627306, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0000733', 'abnormal muscle development', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(627307, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0003157', 'impaired muscle relaxation', 0.4666666666666667, 9.83016599489719, 2.14182417523444, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627308, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627309, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0030144', 'abnormal facial muscle physiology', 0.4117647058823529, 9.83016599489719, 2.011893488647833, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627310, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0012120', 'trophectoderm cell degeneration', 0.40625, 5.059610039003922, 1.4336898473328683, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627311, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0000743', 'muscle spasm', 0.4666666666666667, 9.83016599489719, 2.14182417523444, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627312, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0005620', 'abnormal muscle contractility', 0.4827586206896552, 9.83016599489719, 2.178439206598825, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627313, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0031402', 'decreased muscle fatigability', 0.4827586206896552, 9.83016599489719, 2.178439206598825, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627314, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0001985', 'abnormal gustatory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627315, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0000738', 'impaired muscle contractility', 0.4666666666666667, 9.83016599489719, 2.14182417523444, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627316, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0004142', 'abnormal muscle tone', 0.4827586206896552, 9.83016599489719, 2.178439206598825, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627317, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0030215', 'facial muscle fasciculation', 0.45161290322580644, 9.83016599489719, 2.106995444738103, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627318, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0002106', 'abnormal muscle physiology', 0.5, 9.83016599489719, 2.2169986462441953, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627319, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0004005', 'impaired contractility of intestinal smooth muscle', 0.4375, 9.83016599489719, 2.0738123402968553, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627320, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0004084', 'abnormal cardiac muscle relaxation', 0.4117647058823529, 9.83016599489719, 2.011893488647833, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627321, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0030214', 'muscle fasciculation', 0.4666666666666667, 9.83016599489719, 2.14182417523444, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627322, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0004036', 'abnormal muscle relaxation', 0.4827586206896552, 9.83016599489719, 2.178439206598825, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627323, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0001983', 'abnormal olfactory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627324, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0030216', 'tongue muscle fasciculation', 0.45161290322580644, 9.83016599489719, 2.106995444738103, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627325, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0002952', 'ventricular cardiomyopathy', 0.4117647058823529, 9.83016599489719, 2.011893488647833, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627326, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0002108', 'abnormal muscle morphology', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(627327, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0011808', 'abnormal myoblast differentiation', 0.4166666666666667, 7.206267831629091, 1.7328045465407, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(627328, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0002841', 'impaired skeletal muscle contractility', 0.45161290322580644, 9.83016599489719, 2.106995444738103, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627329, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0002164', 'abnormal gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627330, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0000752', 'dystrophic muscle', 0.41379310344827586, 7.206267831629091, 1.7268190207225766, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(627331, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0000729', 'abnormal myogenesis', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(627332, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0005330', 'cardiomyopathy', 0.42424242424242425, 9.83016599489719, 2.0421492238278343, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627333, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4827586206896552, 9.83016599489719, 2.178439206598825, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627334, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0004037', 'increased muscle relaxation', 0.4666666666666667, 9.83016599489719, 2.14182417523444, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627335, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0004143', 'muscle hypertonia', 0.4666666666666667, 9.83016599489719, 2.14182417523444, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627336, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0004144', 'hypotonia', 0.4375, 9.83016599489719, 2.0738123402968553, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627337, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0009045', 'muscle tetany', 0.45161290322580644, 9.83016599489719, 2.106995444738103, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(627338, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0004233', 'abnormal muscle weight', 0.41935483870967744, 7.206267831629091, 1.7383852519598624, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(627339, 'HP:0003737', 'Mitochondrial myopathy', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627340, 'HP:0030613', 'Abnormal foveal morphology on macular OCT', 'MP:0002697', 'abnormal eye size', 0.4489795918367347, 8.581084971325078, 1.962837748756089, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(627341, 'HP:0030613', 'Abnormal foveal morphology on macular OCT', 'MP:0002699', 'abnormal vitreous body morphology', 0.42, 7.832360208310102, 1.8137230459720808, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(627342, 'HP:0030613', 'Abnormal foveal morphology on macular OCT', 'MP:0009274', 'buphthalmos', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(627343, 'HP:0030613', 'Abnormal foveal morphology on macular OCT', 'MP:0031290', 'bilateral microphthalmia', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(627344, 'HP:0030613', 'Abnormal foveal morphology on macular OCT', 'MP:0003671', 'abnormal eyelid aperture', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(627345, 'HP:0030613', 'Abnormal foveal morphology on macular OCT', 'MP:0001289', 'persistence of hyaloid vascular system', 0.40384615384615385, 7.832360208310102, 1.7785017699354968, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(627346, 'HP:0030613', 'Abnormal foveal morphology on macular OCT', 'MP:0014087', 'retrolental blood', 0.4166666666666667, 7.832360208310102, 1.806511394962459, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(627347, 'HP:0030613', 'Abnormal foveal morphology on macular OCT', 'MP:0006164', 'ectropion', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(627348, 'HP:0030613', 'Abnormal foveal morphology on macular OCT', 'MP:0005195', 'abnormal posterior eye segment morphology', 0.425531914893617, 7.832360208310102, 1.82562845003543, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(627349, 'HP:0030613', 'Abnormal foveal morphology on macular OCT', 'MP:0005176', 'eyelids fail to open', 0.4230769230769231, 8.581084971325078, 1.9053763476882568, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(627350, 'HP:0030613', 'Abnormal foveal morphology on macular OCT', 'MP:0006225', 'ocular rupture', 0.4489795918367347, 8.581084971325078, 1.962837748756089, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(627351, 'HP:0030613', 'Abnormal foveal morphology on macular OCT', 'MP:0006248', 'lagophthalmos', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(627352, 'HP:0030613', 'Abnormal foveal morphology on macular OCT', 'MP:0001297', 'microphthalmia', 0.41509433962264153, 8.581084971325078, 1.887315500762381, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(627353, 'HP:0030613', 'Abnormal foveal morphology on macular OCT', 'MP:0001296', 'macrophthalmia', 0.41509433962264153, 8.581084971325078, 1.887315500762381, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(627354, 'HP:0030613', 'Abnormal foveal morphology on macular OCT', 'MP:0006200', 'vitreous body deposition', 0.4117647058823529, 7.832360208310102, 1.7958534176094256, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(627355, 'HP:0030613', 'Abnormal foveal morphology on macular OCT', 'MP:0003381', 'vitreal fibroplasia', 0.4117647058823529, 7.832360208310102, 1.7958534176094256, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(627356, 'HP:0030613', 'Abnormal foveal morphology on macular OCT', 'MP:0002864', 'abnormal ocular fundus morphology', 0.40816326530612246, 7.832360208310102, 1.7879825831583462, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(627357, 'HP:0030613', 'Abnormal foveal morphology on macular OCT', 'MP:0006249', 'phthisis bulbi', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(627358, 'HP:0030613', 'Abnormal foveal morphology on macular OCT', 'MP:0031289', 'unilateral microphthalmia', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(627359, 'HP:0030613', 'Abnormal foveal morphology on macular OCT', 'MP:0010081', 'posterior microphthalmia', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(627360, 'HP:0030613', 'Abnormal foveal morphology on macular OCT', 'MP:0006209', 'calcified intraocular region', 0.4489795918367347, 8.581084971325078, 1.962837748756089, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(627361, 'HP:0020212', 'Reading-induced seizure', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627362, 'HP:0020212', 'Reading-induced seizure', 'MP:0008840', 'abnormal spike wave discharge', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627363, 'HP:0020212', 'Reading-induced seizure', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627364, 'HP:0020212', 'Reading-induced seizure', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627365, 'HP:0020212', 'Reading-induced seizure', 'MP:0011994', 'increased nerve conduction velocity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627366, 'HP:0020212', 'Reading-induced seizure', 'MP:0011274', 'short excitatory postsynaptic current decay time', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627367, 'HP:0020212', 'Reading-induced seizure', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627368, 'HP:0020212', 'Reading-induced seizure', 'MP:0003220', 'decreased spike-wave discharge type II', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627369, 'HP:0020212', 'Reading-induced seizure', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627370, 'HP:0020212', 'Reading-induced seizure', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627371, 'HP:0020212', 'Reading-induced seizure', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627372, 'HP:0020212', 'Reading-induced seizure', 'MP:0020154', 'impaired humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627373, 'HP:0020212', 'Reading-induced seizure', 'MP:0003488', 'decreased channel response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627374, 'HP:0020212', 'Reading-induced seizure', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627375, 'HP:0020212', 'Reading-induced seizure', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627376, 'HP:0020212', 'Reading-induced seizure', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627377, 'HP:0020212', 'Reading-induced seizure', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627378, 'HP:0020212', 'Reading-induced seizure', 'MP:0009141', 'increased prepulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627379, 'HP:0020212', 'Reading-induced seizure', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627380, 'HP:0020212', 'Reading-induced seizure', 'MP:0002578', 'impaired ability to fire action potentials', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627381, 'HP:0020212', 'Reading-induced seizure', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627382, 'HP:0020212', 'Reading-induced seizure', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627383, 'HP:0020212', 'Reading-induced seizure', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627384, 'HP:0020212', 'Reading-induced seizure', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627385, 'HP:0020212', 'Reading-induced seizure', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627386, 'HP:0020212', 'Reading-induced seizure', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627387, 'HP:0020212', 'Reading-induced seizure', 'MP:0004835', 'abnormal miniature endplate potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627388, 'HP:0020212', 'Reading-induced seizure', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627389, 'HP:0020212', 'Reading-induced seizure', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627390, 'HP:0020212', 'Reading-induced seizure', 'MP:0002207', 'abnormal long-term potentiation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627391, 'HP:0020212', 'Reading-induced seizure', 'MP:0011399', 'increased endoneurial fluid pressure', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627392, 'HP:0020212', 'Reading-induced seizure', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627393, 'HP:0020212', 'Reading-induced seizure', 'MP:0005645', 'abnormal hypothalamus physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627394, 'HP:0020212', 'Reading-induced seizure', 'MP:0011268', 'biphasic excitatory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627395, 'HP:0020212', 'Reading-induced seizure', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627396, 'HP:0020212', 'Reading-induced seizure', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627397, 'HP:0020212', 'Reading-induced seizure', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627398, 'HP:0020212', 'Reading-induced seizure', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627399, 'HP:0020212', 'Reading-induced seizure', 'MP:0009358', 'environmentally induced seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627400, 'HP:0020212', 'Reading-induced seizure', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627401, 'HP:0020212', 'Reading-induced seizure', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627402, 'HP:0020212', 'Reading-induced seizure', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627403, 'HP:0020212', 'Reading-induced seizure', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627404, 'HP:0020212', 'Reading-induced seizure', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627405, 'HP:0020212', 'Reading-induced seizure', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627406, 'HP:0020212', 'Reading-induced seizure', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627407, 'HP:0020212', 'Reading-induced seizure', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627408, 'HP:0020212', 'Reading-induced seizure', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627409, 'HP:0020212', 'Reading-induced seizure', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627410, 'HP:0020212', 'Reading-induced seizure', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627411, 'HP:0020212', 'Reading-induced seizure', 'MP:0011270', 'decreased excitatory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627412, 'HP:0020212', 'Reading-induced seizure', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627413, 'HP:0020212', 'Reading-induced seizure', 'MP:0031333', 'decreased inhibitory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627414, 'HP:0020212', 'Reading-induced seizure', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627415, 'HP:0020212', 'Reading-induced seizure', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627416, 'HP:0020212', 'Reading-induced seizure', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627417, 'HP:0020212', 'Reading-induced seizure', 'MP:0008744', 'abnormal B cell anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627418, 'HP:0020212', 'Reading-induced seizure', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627419, 'HP:0020212', 'Reading-induced seizure', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627420, 'HP:0020212', 'Reading-induced seizure', 'MP:0010653', 'abnormal Wallerian degeneration', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627421, 'HP:0020212', 'Reading-induced seizure', 'MP:0020000', 'abnormal response to antigen', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627422, 'HP:0020212', 'Reading-induced seizure', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627423, 'HP:0020212', 'Reading-induced seizure', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627424, 'HP:0020212', 'Reading-induced seizure', 'MP:0001500', 'decreased kindling response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627425, 'HP:0020212', 'Reading-induced seizure', 'MP:0009142', 'decreased prepulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627426, 'HP:0020212', 'Reading-induced seizure', 'MP:0003482', 'increased nerve fiber response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627427, 'HP:0020212', 'Reading-induced seizure', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627428, 'HP:0020212', 'Reading-induced seizure', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627429, 'HP:0020212', 'Reading-induced seizure', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627430, 'HP:0020212', 'Reading-induced seizure', 'MP:0031334', 'increased inhibitory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627431, 'HP:0020212', 'Reading-induced seizure', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627432, 'HP:0020212', 'Reading-induced seizure', 'MP:0002920', 'decreased paired-pulse facilitation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627433, 'HP:0020212', 'Reading-induced seizure', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627434, 'HP:0020212', 'Reading-induced seizure', 'MP:0003219', 'increased spike-wave discharge type II', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627435, 'HP:0020212', 'Reading-induced seizure', 'MP:0001793', 'abnormal susceptibility to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627436, 'HP:0020212', 'Reading-induced seizure', 'MP:0005000', 'abnormal immune tolerance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627437, 'HP:0020212', 'Reading-induced seizure', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627438, 'HP:0020212', 'Reading-induced seizure', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627439, 'HP:0020212', 'Reading-induced seizure', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627440, 'HP:0020212', 'Reading-induced seizure', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627441, 'HP:0020212', 'Reading-induced seizure', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627442, 'HP:0020212', 'Reading-induced seizure', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627443, 'HP:0020212', 'Reading-induced seizure', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627444, 'HP:0020212', 'Reading-induced seizure', 'MP:0001499', 'abnormal kindling response', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627445, 'HP:0020212', 'Reading-induced seizure', 'MP:0005403', 'abnormal nerve conduction', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627446, 'HP:0020212', 'Reading-induced seizure', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627447, 'HP:0020212', 'Reading-induced seizure', 'MP:0003217', 'increased spike-wave discharge type I', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627448, 'HP:0020212', 'Reading-induced seizure', 'MP:0003777', 'lip inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627449, 'HP:0020212', 'Reading-induced seizure', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627450, 'HP:0020212', 'Reading-induced seizure', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627451, 'HP:0020212', 'Reading-induced seizure', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627452, 'HP:0020212', 'Reading-induced seizure', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627453, 'HP:0020212', 'Reading-induced seizure', 'MP:0002419', 'abnormal innate immunity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627454, 'HP:0020212', 'Reading-induced seizure', 'MP:0011002', 'enhanced AMPA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627455, 'HP:0020212', 'Reading-induced seizure', 'MP:0010368', 'abnormal lymphatic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627456, 'HP:0020212', 'Reading-induced seizure', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627457, 'HP:0020212', 'Reading-induced seizure', 'MP:0004495', 'decreased synaptic glutamate release', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627458, 'HP:0020212', 'Reading-induced seizure', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627459, 'HP:0020212', 'Reading-induced seizure', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627460, 'HP:0020212', 'Reading-induced seizure', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627461, 'HP:0020212', 'Reading-induced seizure', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627462, 'HP:0020212', 'Reading-induced seizure', 'MP:0003466', 'decreased single cell response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627463, 'HP:0020212', 'Reading-induced seizure', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627464, 'HP:0020212', 'Reading-induced seizure', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627465, 'HP:0020212', 'Reading-induced seizure', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627466, 'HP:0020212', 'Reading-induced seizure', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627467, 'HP:0020212', 'Reading-induced seizure', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627468, 'HP:0020212', 'Reading-induced seizure', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627469, 'HP:0020212', 'Reading-induced seizure', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627470, 'HP:0020212', 'Reading-induced seizure', 'MP:0013806', 'encephalopathy', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627471, 'HP:0020212', 'Reading-induced seizure', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627472, 'HP:0020212', 'Reading-induced seizure', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627473, 'HP:0020212', 'Reading-induced seizure', 'MP:0010654', 'slow Wallerian degeneration', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627474, 'HP:0020212', 'Reading-induced seizure', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627475, 'HP:0020212', 'Reading-induced seizure', 'MP:0002500', 'granulomatous inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627476, 'HP:0020212', 'Reading-induced seizure', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627477, 'HP:0020212', 'Reading-induced seizure', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627478, 'HP:0020212', 'Reading-induced seizure', 'MP:0001752', 'abnormal hypothalamus secretion', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627479, 'HP:0020212', 'Reading-induced seizure', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627480, 'HP:0020212', 'Reading-induced seizure', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627481, 'HP:0020212', 'Reading-induced seizure', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627482, 'HP:0020212', 'Reading-induced seizure', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627483, 'HP:0020212', 'Reading-induced seizure', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627484, 'HP:0020212', 'Reading-induced seizure', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627485, 'HP:0020212', 'Reading-induced seizure', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627486, 'HP:0020212', 'Reading-induced seizure', 'MP:0003990', 'decreased neurotransmitter release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627487, 'HP:0020212', 'Reading-induced seizure', 'MP:0003473', 'decreased summary potential threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627488, 'HP:0020212', 'Reading-induced seizure', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627489, 'HP:0020212', 'Reading-induced seizure', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627490, 'HP:0020212', 'Reading-induced seizure', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627491, 'HP:0020212', 'Reading-induced seizure', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627492, 'HP:0020212', 'Reading-induced seizure', 'MP:0006051', 'brainstem hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627493, 'HP:0020212', 'Reading-induced seizure', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627494, 'HP:0020212', 'Reading-induced seizure', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627495, 'HP:0020212', 'Reading-induced seizure', 'MP:0013570', 'abnormal neuroendocrine gland physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627496, 'HP:0020212', 'Reading-induced seizure', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627497, 'HP:0020212', 'Reading-induced seizure', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627498, 'HP:0020212', 'Reading-induced seizure', 'MP:0001837', 'defective assembly of class I molecules', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627499, 'HP:0020212', 'Reading-induced seizure', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627500, 'HP:0020212', 'Reading-induced seizure', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627501, 'HP:0020212', 'Reading-induced seizure', 'MP:0001901', 'absence of NMDA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627502, 'HP:0020212', 'Reading-induced seizure', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627503, 'HP:0020212', 'Reading-induced seizure', 'MP:0005001', 'abnormal clonal deletion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627504, 'HP:0020212', 'Reading-induced seizure', 'MP:0008722', 'abnormal chemokine secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627505, 'HP:0020212', 'Reading-induced seizure', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627506, 'HP:0020212', 'Reading-induced seizure', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627507, 'HP:0020212', 'Reading-induced seizure', 'MP:0006080', 'brain ischemia', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627508, 'HP:0020212', 'Reading-induced seizure', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627509, 'HP:0020212', 'Reading-induced seizure', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627510, 'HP:0020212', 'Reading-induced seizure', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627511, 'HP:0020212', 'Reading-induced seizure', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627512, 'HP:0020212', 'Reading-induced seizure', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627513, 'HP:0020212', 'Reading-induced seizure', 'MP:0003484', 'abnormal channel response', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627514, 'HP:0020212', 'Reading-induced seizure', 'MP:0003088', 'abnormal prepulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627515, 'HP:0020212', 'Reading-induced seizure', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627516, 'HP:0020212', 'Reading-induced seizure', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627517, 'HP:0020212', 'Reading-induced seizure', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627518, 'HP:0020212', 'Reading-induced seizure', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627519, 'HP:0020212', 'Reading-induced seizure', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627520, 'HP:0020212', 'Reading-induced seizure', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627521, 'HP:0020212', 'Reading-induced seizure', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627522, 'HP:0020212', 'Reading-induced seizure', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627523, 'HP:0020212', 'Reading-induced seizure', 'MP:0002885', 'abnormal AMPA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627524, 'HP:0020212', 'Reading-induced seizure', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627525, 'HP:0020212', 'Reading-induced seizure', 'MP:0011272', 'short excitatory postsynaptic current rise time', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627526, 'HP:0020212', 'Reading-induced seizure', 'MP:0001835', 'abnormal antigen presentation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627527, 'HP:0020212', 'Reading-induced seizure', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627528, 'HP:0020212', 'Reading-induced seizure', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627529, 'HP:0020212', 'Reading-induced seizure', 'MP:0001475', 'reduced long-term depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627530, 'HP:0020212', 'Reading-induced seizure', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627531, 'HP:0020212', 'Reading-induced seizure', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627532, 'HP:0020212', 'Reading-induced seizure', 'MP:0003465', 'increased single cell response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627533, 'HP:0020212', 'Reading-induced seizure', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627534, 'HP:0020212', 'Reading-induced seizure', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627535, 'HP:0020212', 'Reading-induced seizure', 'MP:0003477', 'abnormal nerve fiber response', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627536, 'HP:0020212', 'Reading-induced seizure', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627537, 'HP:0020212', 'Reading-induced seizure', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627538, 'HP:0020212', 'Reading-induced seizure', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627539, 'HP:0020212', 'Reading-induced seizure', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627540, 'HP:0020212', 'Reading-induced seizure', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627541, 'HP:0020212', 'Reading-induced seizure', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627542, 'HP:0020212', 'Reading-induced seizure', 'MP:0003470', 'abnormal summary potential', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627543, 'HP:0020212', 'Reading-induced seizure', 'MP:0003487', 'increased channel response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627544, 'HP:0020212', 'Reading-induced seizure', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627545, 'HP:0020212', 'Reading-induced seizure', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627546, 'HP:0020212', 'Reading-induced seizure', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627547, 'HP:0020212', 'Reading-induced seizure', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627548, 'HP:0020212', 'Reading-induced seizure', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627549, 'HP:0020212', 'Reading-induced seizure', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627550, 'HP:0020212', 'Reading-induced seizure', 'MP:0006052', 'cerebellum hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627551, 'HP:0020212', 'Reading-induced seizure', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627552, 'HP:0020212', 'Reading-induced seizure', 'MP:0002499', 'chronic inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627553, 'HP:0020212', 'Reading-induced seizure', 'MP:0011003', 'reduced AMPA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627554, 'HP:0020212', 'Reading-induced seizure', 'MP:0002195', 'psychomotor seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627555, 'HP:0020212', 'Reading-induced seizure', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627556, 'HP:0020212', 'Reading-induced seizure', 'MP:0003483', 'decreased nerve fiber response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627557, 'HP:0020212', 'Reading-induced seizure', 'MP:0002916', 'increased synaptic depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627558, 'HP:0020212', 'Reading-induced seizure', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627559, 'HP:0020212', 'Reading-induced seizure', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627560, 'HP:0020212', 'Reading-induced seizure', 'MP:0001902', 'reduced NMDA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627561, 'HP:0020212', 'Reading-induced seizure', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627562, 'HP:0020212', 'Reading-induced seizure', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627563, 'HP:0020212', 'Reading-induced seizure', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627564, 'HP:0020212', 'Reading-induced seizure', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627565, 'HP:0020212', 'Reading-induced seizure', 'MP:0003463', 'abnormal single cell response', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627566, 'HP:0020212', 'Reading-induced seizure', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627567, 'HP:0020212', 'Reading-induced seizure', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627568, 'HP:0020212', 'Reading-induced seizure', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627569, 'HP:0020212', 'Reading-induced seizure', 'MP:0012565', 'perivasculitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627570, 'HP:0020212', 'Reading-induced seizure', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627571, 'HP:0020212', 'Reading-induced seizure', 'MP:0014178', 'increased brain apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627572, 'HP:0020212', 'Reading-induced seizure', 'MP:0004859', 'abnormal synaptic plasticity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627573, 'HP:0020212', 'Reading-induced seizure', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627574, 'HP:0020212', 'Reading-induced seizure', 'MP:0003997', 'tonic-clonic seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627575, 'HP:0020212', 'Reading-induced seizure', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627576, 'HP:0020212', 'Reading-induced seizure', 'MP:0005043', 'defective assembly of class II molecules', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627577, 'HP:0020212', 'Reading-induced seizure', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627578, 'HP:0020212', 'Reading-induced seizure', 'MP:0002826', 'tonic seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627579, 'HP:0020212', 'Reading-induced seizure', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627580, 'HP:0020212', 'Reading-induced seizure', 'MP:0014255', 'increased paired-pulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627581, 'HP:0020212', 'Reading-induced seizure', 'MP:0001845', 'abnormal inflammatory response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627582, 'HP:0020212', 'Reading-induced seizure', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627583, 'HP:0020212', 'Reading-induced seizure', 'MP:0021001', 'impaired neuron physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627584, 'HP:0020212', 'Reading-induced seizure', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627585, 'HP:0020212', 'Reading-induced seizure', 'MP:0020155', 'enhanced humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627586, 'HP:0020212', 'Reading-induced seizure', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627587, 'HP:0020212', 'Reading-induced seizure', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627588, 'HP:0020212', 'Reading-induced seizure', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627589, 'HP:0020212', 'Reading-induced seizure', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627590, 'HP:0020212', 'Reading-induced seizure', 'MP:0002723', 'abnormal immune serum protein physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627591, 'HP:0020212', 'Reading-induced seizure', 'MP:0004752', 'decreased length of allograft survival', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627592, 'HP:0020212', 'Reading-induced seizure', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627593, 'HP:0020212', 'Reading-induced seizure', 'MP:0003472', 'increased summary potential threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627594, 'HP:0020212', 'Reading-induced seizure', 'MP:0021016', 'decreased tau protein phosphorylation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627595, 'HP:0020212', 'Reading-induced seizure', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627596, 'HP:0020212', 'Reading-induced seizure', 'MP:0011267', 'abnormal excitatory postsynaptic current amplitude', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627597, 'HP:0020212', 'Reading-induced seizure', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627598, 'HP:0020212', 'Reading-induced seizure', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627599, 'HP:0020212', 'Reading-induced seizure', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627600, 'HP:0020212', 'Reading-induced seizure', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627601, 'HP:0020212', 'Reading-induced seizure', 'MP:0002914', 'abnormal endplate potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627602, 'HP:0020212', 'Reading-induced seizure', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627603, 'HP:0020212', 'Reading-induced seizure', 'MP:0003009', 'abnormal cytokine secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627604, 'HP:0020212', 'Reading-induced seizure', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627605, 'HP:0020212', 'Reading-induced seizure', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627606, 'HP:0020212', 'Reading-induced seizure', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627607, 'HP:0020212', 'Reading-induced seizure', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627608, 'HP:0020212', 'Reading-induced seizure', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627609, 'HP:0020212', 'Reading-induced seizure', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627610, 'HP:0020212', 'Reading-induced seizure', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627611, 'HP:0020212', 'Reading-induced seizure', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627612, 'HP:0020212', 'Reading-induced seizure', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627613, 'HP:0020212', 'Reading-induced seizure', 'MP:0030153', 'dental pulp inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627614, 'HP:0020212', 'Reading-induced seizure', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627615, 'HP:0020212', 'Reading-induced seizure', 'MP:0020371', 'abnormal glymphatic system physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627616, 'HP:0020212', 'Reading-induced seizure', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627617, 'HP:0020212', 'Reading-induced seizure', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627618, 'HP:0020212', 'Reading-induced seizure', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627619, 'HP:0020212', 'Reading-induced seizure', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627620, 'HP:0020212', 'Reading-induced seizure', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627621, 'HP:0020212', 'Reading-induced seizure', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627622, 'HP:0020212', 'Reading-induced seizure', 'MP:0014256', 'decreased paired-pulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627623, 'HP:0020212', 'Reading-induced seizure', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627624, 'HP:0020212', 'Reading-induced seizure', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627625, 'HP:0020212', 'Reading-induced seizure', 'MP:0001898', 'abnormal long-term depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627626, 'HP:0020212', 'Reading-induced seizure', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627627, 'HP:0020212', 'Reading-induced seizure', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627628, 'HP:0020212', 'Reading-induced seizure', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627629, 'HP:0020212', 'Reading-induced seizure', 'MP:0003490', 'decreased channel response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627630, 'HP:0020212', 'Reading-induced seizure', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627631, 'HP:0020212', 'Reading-induced seizure', 'MP:0003476', 'decreased summary potential intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627632, 'HP:0020212', 'Reading-induced seizure', 'MP:0004494', 'abnormal synaptic glutamate release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627633, 'HP:0020212', 'Reading-induced seizure', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627634, 'HP:0020212', 'Reading-induced seizure', 'MP:0021082', 'abnormal cerebrospinal fluid amyloid beta 42 isoform level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627635, 'HP:0020212', 'Reading-induced seizure', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627636, 'HP:0020212', 'Reading-induced seizure', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627637, 'HP:0020212', 'Reading-induced seizure', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627638, 'HP:0020212', 'Reading-induced seizure', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627639, 'HP:0020212', 'Reading-induced seizure', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627640, 'HP:0020212', 'Reading-induced seizure', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627641, 'HP:0020212', 'Reading-induced seizure', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627642, 'HP:0020212', 'Reading-induced seizure', 'MP:0001876', 'decreased inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627643, 'HP:0020212', 'Reading-induced seizure', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627644, 'HP:0020212', 'Reading-induced seizure', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627645, 'HP:0020212', 'Reading-induced seizure', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627646, 'HP:0020212', 'Reading-induced seizure', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627647, 'HP:0020212', 'Reading-induced seizure', 'MP:0001900', 'impaired synaptic plasticity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627648, 'HP:0020212', 'Reading-induced seizure', 'MP:0002634', 'abnormal sensorimotor gating', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627649, 'HP:0020212', 'Reading-induced seizure', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627650, 'HP:0020212', 'Reading-induced seizure', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627651, 'HP:0020212', 'Reading-induced seizure', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627652, 'HP:0020212', 'Reading-induced seizure', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627653, 'HP:0020212', 'Reading-induced seizure', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627654, 'HP:0020212', 'Reading-induced seizure', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627655, 'HP:0020212', 'Reading-induced seizure', 'MP:0002635', 'reduced sensorimotor gating', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627656, 'HP:0020212', 'Reading-induced seizure', 'MP:0003480', 'increased nerve fiber response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627657, 'HP:0020212', 'Reading-induced seizure', 'MP:0003471', 'abnormal summary potential threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627658, 'HP:0020212', 'Reading-induced seizure', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627659, 'HP:0020212', 'Reading-induced seizure', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627660, 'HP:0020212', 'Reading-induced seizure', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627661, 'HP:0020212', 'Reading-induced seizure', 'MP:0003469', 'decreased single cell response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627662, 'HP:0020212', 'Reading-induced seizure', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627663, 'HP:0020212', 'Reading-induced seizure', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627664, 'HP:0020212', 'Reading-induced seizure', 'MP:0009967', 'abnormal neuron proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627665, 'HP:0020212', 'Reading-induced seizure', 'MP:0005005', 'abnormal self tolerance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627666, 'HP:0020212', 'Reading-induced seizure', 'MP:0005402', 'abnormal action potential', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627667, 'HP:0020212', 'Reading-induced seizure', 'MP:0002498', 'abnormal acute inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627668, 'HP:0020212', 'Reading-induced seizure', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627669, 'HP:0020212', 'Reading-induced seizure', 'MP:0030129', 'tongue inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627670, 'HP:0020212', 'Reading-induced seizure', 'MP:0001790', 'abnormal immune system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627671, 'HP:0020212', 'Reading-induced seizure', 'MP:0006060', 'increased cerebral infarct size', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627672, 'HP:0020212', 'Reading-induced seizure', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627673, 'HP:0020212', 'Reading-induced seizure', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627674, 'HP:0020212', 'Reading-induced seizure', 'MP:0013438', 'dysmyelination', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627675, 'HP:0020212', 'Reading-induced seizure', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627676, 'HP:0020212', 'Reading-induced seizure', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627677, 'HP:0020212', 'Reading-induced seizure', 'MP:0011271', 'prolonged excitatory postsynaptic current rise time', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627678, 'HP:0020212', 'Reading-induced seizure', 'MP:0010746', 'abnormal pre-Botzinger complex physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627679, 'HP:0020212', 'Reading-induced seizure', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627680, 'HP:0020212', 'Reading-induced seizure', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627681, 'HP:0020212', 'Reading-induced seizure', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627682, 'HP:0020212', 'Reading-induced seizure', 'MP:0021027', 'abnormal cerebrospinal fluid amyloid beta 40 isoform level', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627683, 'HP:0020212', 'Reading-induced seizure', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627684, 'HP:0020212', 'Reading-induced seizure', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627685, 'HP:0020212', 'Reading-induced seizure', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627686, 'HP:0020212', 'Reading-induced seizure', 'MP:0001916', 'intracerebral hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627687, 'HP:0020212', 'Reading-induced seizure', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627688, 'HP:0020212', 'Reading-induced seizure', 'MP:0011269', 'increased excitatory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627689, 'HP:0020212', 'Reading-induced seizure', 'MP:0004751', 'increased length of allograft survival', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627690, 'HP:0020212', 'Reading-induced seizure', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627691, 'HP:0020212', 'Reading-induced seizure', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627692, 'HP:0020212', 'Reading-induced seizure', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627693, 'HP:0020212', 'Reading-induced seizure', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627694, 'HP:0020212', 'Reading-induced seizure', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627695, 'HP:0020212', 'Reading-induced seizure', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627696, 'HP:0020212', 'Reading-induced seizure', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627697, 'HP:0020212', 'Reading-induced seizure', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627698, 'HP:0020212', 'Reading-induced seizure', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627699, 'HP:0020212', 'Reading-induced seizure', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627700, 'HP:0020212', 'Reading-induced seizure', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627701, 'HP:0020212', 'Reading-induced seizure', 'MP:0031110', 'meningitis', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627702, 'HP:0020212', 'Reading-induced seizure', 'MP:0012503', 'increased midbrain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627703, 'HP:0020212', 'Reading-induced seizure', 'MP:0001496', 'audiogenic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627704, 'HP:0020212', 'Reading-induced seizure', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627705, 'HP:0020212', 'Reading-induced seizure', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627706, 'HP:0020212', 'Reading-induced seizure', 'MP:0011397', 'endoneurial edema', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627707, 'HP:0020212', 'Reading-induced seizure', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627708, 'HP:0020212', 'Reading-induced seizure', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627709, 'HP:0020212', 'Reading-induced seizure', 'MP:0021010', 'impaired synaptic physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627710, 'HP:0020212', 'Reading-induced seizure', 'MP:0011273', 'prolonged excitatory postsynaptic current decay time', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627711, 'HP:0020212', 'Reading-induced seizure', 'MP:0003474', 'abnormal summary potential intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627712, 'HP:0020212', 'Reading-induced seizure', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627713, 'HP:0020212', 'Reading-induced seizure', 'MP:0031117', 'subdural hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627714, 'HP:0020212', 'Reading-induced seizure', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627715, 'HP:0020212', 'Reading-induced seizure', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627716, 'HP:0020212', 'Reading-induced seizure', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627717, 'HP:0020212', 'Reading-induced seizure', 'MP:0005004', 'abnormal lymphocyte anergy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627718, 'HP:0020212', 'Reading-induced seizure', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627719, 'HP:0020212', 'Reading-induced seizure', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627720, 'HP:0020212', 'Reading-induced seizure', 'MP:0002906', 'increased susceptibility to pharmacologically induced seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627721, 'HP:0020212', 'Reading-induced seizure', 'MP:0004768', 'abnormal axonal transport', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627722, 'HP:0020212', 'Reading-induced seizure', 'MP:0031332', 'abnormal inhibitory postsynaptic current amplitude', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627723, 'HP:0020212', 'Reading-induced seizure', 'MP:0010149', 'abnormal synaptic dopamine release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627724, 'HP:0020212', 'Reading-induced seizure', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627725, 'HP:0020212', 'Reading-induced seizure', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627726, 'HP:0020212', 'Reading-induced seizure', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627727, 'HP:0020212', 'Reading-induced seizure', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627728, 'HP:0020212', 'Reading-induced seizure', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627729, 'HP:0020212', 'Reading-induced seizure', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627730, 'HP:0020212', 'Reading-induced seizure', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627731, 'HP:0020212', 'Reading-induced seizure', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627732, 'HP:0020212', 'Reading-induced seizure', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627733, 'HP:0020212', 'Reading-induced seizure', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627734, 'HP:0020212', 'Reading-induced seizure', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627735, 'HP:0020212', 'Reading-induced seizure', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627736, 'HP:0020212', 'Reading-induced seizure', 'MP:0004811', 'abnormal neuron physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627737, 'HP:0020212', 'Reading-induced seizure', 'MP:0012261', 'increased hindbrain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627738, 'HP:0020212', 'Reading-induced seizure', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627739, 'HP:0020212', 'Reading-induced seizure', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627740, 'HP:0020212', 'Reading-induced seizure', 'MP:0004513', 'avnosmia', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627741, 'HP:0020212', 'Reading-induced seizure', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627742, 'HP:0020212', 'Reading-induced seizure', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627743, 'HP:0020212', 'Reading-induced seizure', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627744, 'HP:0020212', 'Reading-induced seizure', 'MP:0014179', 'abnormal blood-retina barrier function', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627745, 'HP:0020212', 'Reading-induced seizure', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627746, 'HP:0020212', 'Reading-induced seizure', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627747, 'HP:0020212', 'Reading-induced seizure', 'MP:0014252', 'abnormal paired-pulse ratio', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627748, 'HP:0020212', 'Reading-induced seizure', 'MP:0003216', 'absence seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627749, 'HP:0020212', 'Reading-induced seizure', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627750, 'HP:0020212', 'Reading-induced seizure', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627751, 'HP:0020212', 'Reading-induced seizure', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627752, 'HP:0020212', 'Reading-induced seizure', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627753, 'HP:0020212', 'Reading-induced seizure', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627754, 'HP:0020212', 'Reading-induced seizure', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627755, 'HP:0020212', 'Reading-induced seizure', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627756, 'HP:0020212', 'Reading-induced seizure', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627757, 'HP:0020212', 'Reading-induced seizure', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627758, 'HP:0020212', 'Reading-induced seizure', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627759, 'HP:0020212', 'Reading-induced seizure', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627760, 'HP:0020212', 'Reading-induced seizure', 'MP:0001844', 'autoimmune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627761, 'HP:0020212', 'Reading-induced seizure', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627762, 'HP:0020212', 'Reading-induced seizure', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627763, 'HP:0020212', 'Reading-induced seizure', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627764, 'HP:0020212', 'Reading-induced seizure', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627765, 'HP:0020212', 'Reading-induced seizure', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627766, 'HP:0020212', 'Reading-induced seizure', 'MP:0002922', 'decreased post-tetanic potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627767, 'HP:0020212', 'Reading-induced seizure', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627768, 'HP:0020212', 'Reading-induced seizure', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627769, 'HP:0020212', 'Reading-induced seizure', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627770, 'HP:0020212', 'Reading-induced seizure', 'MP:0031109', 'subarachnoid hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627771, 'HP:0020212', 'Reading-induced seizure', 'MP:0014120', 'focal seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627772, 'HP:0020212', 'Reading-induced seizure', 'MP:0005025', 'abnormal response to infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627773, 'HP:0020212', 'Reading-induced seizure', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627774, 'HP:0020212', 'Reading-induced seizure', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627775, 'HP:0020212', 'Reading-induced seizure', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627776, 'HP:0020212', 'Reading-induced seizure', 'MP:0012502', 'decreased hindbrain apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627777, 'HP:0020212', 'Reading-induced seizure', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627778, 'HP:0020212', 'Reading-induced seizure', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627779, 'HP:0020212', 'Reading-induced seizure', 'MP:0001912', 'increased cerebrospinal fluid production', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627780, 'HP:0020212', 'Reading-induced seizure', 'MP:0003464', 'abnormal single cell response threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627781, 'HP:0020212', 'Reading-induced seizure', 'MP:0008555', 'abnormal interferon secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627782, 'HP:0020212', 'Reading-induced seizure', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627783, 'HP:0020212', 'Reading-induced seizure', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627784, 'HP:0020212', 'Reading-induced seizure', 'MP:0003762', 'abnormal immune organ physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627785, 'HP:0020212', 'Reading-induced seizure', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627786, 'HP:0020212', 'Reading-induced seizure', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627787, 'HP:0020212', 'Reading-induced seizure', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627788, 'HP:0020212', 'Reading-induced seizure', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627789, 'HP:0020212', 'Reading-induced seizure', 'MP:0021015', 'increased tau protein phosphorylation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627790, 'HP:0020212', 'Reading-induced seizure', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627791, 'HP:0020212', 'Reading-induced seizure', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627792, 'HP:0020212', 'Reading-induced seizure', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627793, 'HP:0020212', 'Reading-induced seizure', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627794, 'HP:0020212', 'Reading-induced seizure', 'MP:0012011', 'febrile seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627795, 'HP:0020212', 'Reading-induced seizure', 'MP:0001800', 'abnormal humoral immune response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627796, 'HP:0020212', 'Reading-induced seizure', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627797, 'HP:0020212', 'Reading-induced seizure', 'MP:0001846', 'increased inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627798, 'HP:0020212', 'Reading-induced seizure', 'MP:0011001', 'absence of AMPA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627799, 'HP:0020212', 'Reading-induced seizure', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627800, 'HP:0020212', 'Reading-induced seizure', 'MP:0021009', 'abnormal synaptic physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627801, 'HP:0020212', 'Reading-induced seizure', 'MP:0001473', 'reduced long-term potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627802, 'HP:0020212', 'Reading-induced seizure', 'MP:0003467', 'abnormal single cell response intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627803, 'HP:0020212', 'Reading-induced seizure', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627804, 'HP:0020212', 'Reading-induced seizure', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627805, 'HP:0020212', 'Reading-induced seizure', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627806, 'HP:0020212', 'Reading-induced seizure', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627807, 'HP:0020212', 'Reading-induced seizure', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627808, 'HP:0020212', 'Reading-induced seizure', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627809, 'HP:0020212', 'Reading-induced seizure', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627810, 'HP:0020212', 'Reading-induced seizure', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627811, 'HP:0020212', 'Reading-induced seizure', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627812, 'HP:0020212', 'Reading-induced seizure', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627813, 'HP:0020212', 'Reading-induced seizure', 'MP:0020001', 'decreased response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627814, 'HP:0020212', 'Reading-induced seizure', 'MP:0013182', 'increased spinal cord apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627815, 'HP:0020212', 'Reading-induced seizure', 'MP:0003475', 'increased summary potential intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627816, 'HP:0020212', 'Reading-induced seizure', 'MP:0008921', 'increased neurotransmitter release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627817, 'HP:0020212', 'Reading-induced seizure', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627818, 'HP:0020212', 'Reading-induced seizure', 'MP:0002193', 'minimal clonic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627819, 'HP:0020212', 'Reading-induced seizure', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627820, 'HP:0020212', 'Reading-induced seizure', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627821, 'HP:0020212', 'Reading-induced seizure', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627822, 'HP:0020212', 'Reading-induced seizure', 'MP:0012504', 'increased forebrain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627823, 'HP:0020212', 'Reading-induced seizure', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627824, 'HP:0020212', 'Reading-induced seizure', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627825, 'HP:0020212', 'Reading-induced seizure', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627826, 'HP:0020212', 'Reading-induced seizure', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627827, 'HP:0020212', 'Reading-induced seizure', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627828, 'HP:0020212', 'Reading-induced seizure', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627829, 'HP:0020212', 'Reading-induced seizure', 'MP:0003996', 'clonic seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627830, 'HP:0020212', 'Reading-induced seizure', 'MP:0003485', 'abnormal channel response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627831, 'HP:0020212', 'Reading-induced seizure', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627832, 'HP:0020212', 'Reading-induced seizure', 'MP:0003412', 'abnormal afterhyperpolarization', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627833, 'HP:0020212', 'Reading-induced seizure', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627834, 'HP:0020212', 'Reading-induced seizure', 'MP:0010050', 'hypermyelination', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627835, 'HP:0020212', 'Reading-induced seizure', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627836, 'HP:0020212', 'Reading-induced seizure', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627837, 'HP:0020212', 'Reading-induced seizure', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627838, 'HP:0020212', 'Reading-induced seizure', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627839, 'HP:0020212', 'Reading-induced seizure', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627840, 'HP:0020212', 'Reading-induced seizure', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627841, 'HP:0020212', 'Reading-induced seizure', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627842, 'HP:0020212', 'Reading-induced seizure', 'MP:0002888', 'abnormal NMDA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627843, 'HP:0020212', 'Reading-induced seizure', 'MP:0002420', 'abnormal adaptive immunity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627844, 'HP:0020212', 'Reading-induced seizure', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627845, 'HP:0020212', 'Reading-induced seizure', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627846, 'HP:0020212', 'Reading-induced seizure', 'MP:0003218', 'decreased spike-wave discharge type I', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627847, 'HP:0020212', 'Reading-induced seizure', 'MP:0003489', 'increased channel response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627848, 'HP:0020212', 'Reading-induced seizure', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627849, 'HP:0020212', 'Reading-induced seizure', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627850, 'HP:0020212', 'Reading-induced seizure', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627851, 'HP:0020212', 'Reading-induced seizure', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627852, 'HP:0020212', 'Reading-induced seizure', 'MP:0003234', 'enhanced NMDA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627853, 'HP:0020212', 'Reading-induced seizure', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627854, 'HP:0020212', 'Reading-induced seizure', 'MP:0002471', 'abnormal complement pathway', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627855, 'HP:0020212', 'Reading-induced seizure', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627856, 'HP:0020212', 'Reading-induced seizure', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627857, 'HP:0020212', 'Reading-induced seizure', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627858, 'HP:0020212', 'Reading-induced seizure', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627859, 'HP:0020212', 'Reading-induced seizure', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627860, 'HP:0020212', 'Reading-induced seizure', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627861, 'HP:0020212', 'Reading-induced seizure', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627862, 'HP:0020212', 'Reading-induced seizure', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627863, 'HP:0020212', 'Reading-induced seizure', 'MP:0006053', 'hypothalamus hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627864, 'HP:0020212', 'Reading-induced seizure', 'MP:0001917', 'intraventricular hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627865, 'HP:0020212', 'Reading-induced seizure', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627866, 'HP:0020212', 'Reading-induced seizure', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627867, 'HP:0020212', 'Reading-induced seizure', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627868, 'HP:0020212', 'Reading-induced seizure', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627869, 'HP:0020212', 'Reading-induced seizure', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627870, 'HP:0020212', 'Reading-induced seizure', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627871, 'HP:0020212', 'Reading-induced seizure', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627872, 'HP:0020212', 'Reading-induced seizure', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627873, 'HP:0020212', 'Reading-induced seizure', 'MP:0003635', 'abnormal synaptic transmission', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627874, 'HP:0020212', 'Reading-induced seizure', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627875, 'HP:0020212', 'Reading-induced seizure', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627876, 'HP:0020212', 'Reading-induced seizure', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627877, 'HP:0020212', 'Reading-induced seizure', 'MP:0003008', 'enhanced long-term potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627878, 'HP:0020212', 'Reading-induced seizure', 'MP:0005044', 'sepsis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627879, 'HP:0020212', 'Reading-induced seizure', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627880, 'HP:0020212', 'Reading-induced seizure', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627881, 'HP:0020212', 'Reading-induced seizure', 'MP:0030132', 'periodontium inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627882, 'HP:0020212', 'Reading-induced seizure', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627883, 'HP:0020212', 'Reading-induced seizure', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627884, 'HP:0020212', 'Reading-induced seizure', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627885, 'HP:0020212', 'Reading-induced seizure', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627886, 'HP:0020212', 'Reading-induced seizure', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627887, 'HP:0020212', 'Reading-induced seizure', 'MP:0003202', 'abnormal neuron apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627888, 'HP:0020212', 'Reading-induced seizure', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627889, 'HP:0020212', 'Reading-induced seizure', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627890, 'HP:0020212', 'Reading-induced seizure', 'MP:0003889', 'enhanced sensorimotor gating', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627891, 'HP:0020212', 'Reading-induced seizure', 'MP:0008747', 'abnormal T cell anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627892, 'HP:0020212', 'Reading-induced seizure', 'MP:0020424', 'increased kindling response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627893, 'HP:0020212', 'Reading-induced seizure', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627894, 'HP:0020212', 'Reading-induced seizure', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627895, 'HP:0020212', 'Reading-induced seizure', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627896, 'HP:0020212', 'Reading-induced seizure', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627897, 'HP:0020212', 'Reading-induced seizure', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627898, 'HP:0020212', 'Reading-induced seizure', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627899, 'HP:0020212', 'Reading-induced seizure', 'MP:0008568', 'abnormal interleukin secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627900, 'HP:0020212', 'Reading-induced seizure', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627901, 'HP:0020212', 'Reading-induced seizure', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627902, 'HP:0020212', 'Reading-induced seizure', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627903, 'HP:0020212', 'Reading-induced seizure', 'MP:0000920', 'abnormal myelination', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627904, 'HP:0020212', 'Reading-induced seizure', 'MP:0014254', 'increased paired-pulse ratio', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627905, 'HP:0020212', 'Reading-induced seizure', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627906, 'HP:0020212', 'Reading-induced seizure', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627907, 'HP:0020212', 'Reading-induced seizure', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627908, 'HP:0020212', 'Reading-induced seizure', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627909, 'HP:0020212', 'Reading-induced seizure', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627910, 'HP:0020212', 'Reading-induced seizure', 'MP:0000948', 'nonconvulsive seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627911, 'HP:0020212', 'Reading-induced seizure', 'MP:0006058', 'decreased cerebral infarct size', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627912, 'HP:0020212', 'Reading-induced seizure', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627913, 'HP:0020212', 'Reading-induced seizure', 'MP:0002915', 'abnormal synaptic depression', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627914, 'HP:0020212', 'Reading-induced seizure', 'MP:0003880', 'abnormal central pattern generator function', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627915, 'HP:0020212', 'Reading-induced seizure', 'MP:0001915', 'intracranial hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627916, 'HP:0020212', 'Reading-induced seizure', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627917, 'HP:0020212', 'Reading-induced seizure', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627918, 'HP:0020212', 'Reading-induced seizure', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627919, 'HP:0020212', 'Reading-induced seizure', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627920, 'HP:0020212', 'Reading-induced seizure', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627921, 'HP:0020212', 'Reading-induced seizure', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627922, 'HP:0020212', 'Reading-induced seizure', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627923, 'HP:0020212', 'Reading-induced seizure', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627924, 'HP:0020212', 'Reading-induced seizure', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627925, 'HP:0020212', 'Reading-induced seizure', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627926, 'HP:0020212', 'Reading-induced seizure', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627927, 'HP:0020212', 'Reading-induced seizure', 'MP:0014253', 'decreased paired-pulse ratio', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627928, 'HP:0020212', 'Reading-induced seizure', 'MP:0002064', 'seizures', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627929, 'HP:0020212', 'Reading-induced seizure', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627930, 'HP:0020212', 'Reading-induced seizure', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627931, 'HP:0020212', 'Reading-induced seizure', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627932, 'HP:0020212', 'Reading-induced seizure', 'MP:0002421', 'abnormal cell-mediated immunity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627933, 'HP:0020212', 'Reading-induced seizure', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627934, 'HP:0020212', 'Reading-induced seizure', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627935, 'HP:0020212', 'Reading-induced seizure', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627936, 'HP:0020212', 'Reading-induced seizure', 'MP:0003486', 'abnormal channel response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627937, 'HP:0020212', 'Reading-induced seizure', 'MP:0013596', 'abnormal vomeronasal organ physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627938, 'HP:0020212', 'Reading-induced seizure', 'MP:0003468', 'increased single cell response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627939, 'HP:0020212', 'Reading-induced seizure', 'MP:0008814', 'decreased nerve conduction velocity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627940, 'HP:0020212', 'Reading-induced seizure', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627941, 'HP:0020212', 'Reading-induced seizure', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627942, 'HP:0020212', 'Reading-induced seizure', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627943, 'HP:0020212', 'Reading-induced seizure', 'MP:0003481', 'decreased nerve fiber response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627944, 'HP:0020212', 'Reading-induced seizure', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627945, 'HP:0020212', 'Reading-induced seizure', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627946, 'HP:0020212', 'Reading-induced seizure', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627947, 'HP:0020212', 'Reading-induced seizure', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627948, 'HP:0020212', 'Reading-induced seizure', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627949, 'HP:0020212', 'Reading-induced seizure', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627950, 'HP:0020212', 'Reading-induced seizure', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627951, 'HP:0020212', 'Reading-induced seizure', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627952, 'HP:0020212', 'Reading-induced seizure', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627953, 'HP:0020212', 'Reading-induced seizure', 'MP:0004994', 'abnormal brain wave pattern', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627954, 'HP:0020212', 'Reading-induced seizure', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627955, 'HP:0020212', 'Reading-induced seizure', 'MP:0000947', 'convulsive seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627956, 'HP:0020212', 'Reading-induced seizure', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627957, 'HP:0020212', 'Reading-induced seizure', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627958, 'HP:0020212', 'Reading-induced seizure', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627959, 'HP:0020212', 'Reading-induced seizure', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627960, 'HP:0020212', 'Reading-induced seizure', 'MP:0006054', 'spinal hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627961, 'HP:0020212', 'Reading-induced seizure', 'MP:0012006', 'abnormal hippocampus physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627962, 'HP:0020212', 'Reading-induced seizure', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627963, 'HP:0020212', 'Reading-induced seizure', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627964, 'HP:0020212', 'Reading-induced seizure', 'MP:0001847', 'brain inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627965, 'HP:0020212', 'Reading-induced seizure', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627966, 'HP:0020212', 'Reading-induced seizure', 'MP:0003633', 'abnormal nervous system physiology', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627967, 'HP:0020212', 'Reading-induced seizure', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627968, 'HP:0020212', 'Reading-induced seizure', 'MP:0002887', 'decreased susceptibility to pharmacologically induced seizures', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627969, 'HP:0020212', 'Reading-induced seizure', 'MP:0002917', 'decreased synaptic depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627970, 'HP:0020212', 'Reading-induced seizure', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627971, 'HP:0020212', 'Reading-induced seizure', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627972, 'HP:0020212', 'Reading-induced seizure', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627973, 'HP:0020212', 'Reading-induced seizure', 'MP:0000951', 'sporadic seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627974, 'HP:0020212', 'Reading-induced seizure', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627975, 'HP:0020212', 'Reading-induced seizure', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627976, 'HP:0020212', 'Reading-induced seizure', 'MP:0000921', 'demyelination', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627977, 'HP:0020212', 'Reading-induced seizure', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627978, 'HP:0020212', 'Reading-induced seizure', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627979, 'HP:0020212', 'Reading-induced seizure', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627980, 'HP:0020212', 'Reading-induced seizure', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627981, 'HP:0020212', 'Reading-induced seizure', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627982, 'HP:0020212', 'Reading-induced seizure', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627983, 'HP:0020212', 'Reading-induced seizure', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627984, 'HP:0020212', 'Reading-induced seizure', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627985, 'HP:0020212', 'Reading-induced seizure', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627986, 'HP:0020212', 'Reading-induced seizure', 'MP:0020002', 'increased response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627987, 'HP:0020212', 'Reading-induced seizure', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627988, 'HP:0020212', 'Reading-induced seizure', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627989, 'HP:0020212', 'Reading-induced seizure', 'MP:0002923', 'increased post-tetanic potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(627990, 'HP:0020212', 'Reading-induced seizure', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627991, 'HP:0020212', 'Reading-induced seizure', 'MP:0005671', 'abnormal response to transplant', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(627992, 'HP:0020212', 'Reading-induced seizure', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
